Dactolisib (BEZ235)

For research use only. Not for use in humans.

目录号：S1009 别名： NVP-BEZ235 中文名称：达克利司

CAS No. 915019-65-7

Dactolisib (BEZ235, NVP-BEZ235) 是一种双重ATP竞争性 PI3K 和 mTOR 抑制剂，在无细胞试验中，抑制 p110α/γ/δ/β 和 mTOR(p70S6K) 的 IC50 分别为 4 nM /5 nM /7 nM /75 nM /6 nM。在 3T3^TopBP1-ER 细胞中抑制 ATR，IC50 为 21 nM，而对 Akt 和 PDK1 的抑制作用很弱。Dactolisib可诱导自噬并抑制HIV-1的复制。Phase 2。

规格

价格

库存

购买数量

50mg	RMB 895.88	现货
100mg	RMB 1414.41	现货
200mg	RMB 2530.71	现货
大包装	有超大折扣

大剂量询单有大折扣!

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Dactolisib (BEZ235)发表文献369篇：

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Cancer Cell, 2019, 35(5):752-766

PubMed: 31085176 ( click the link to review the publication )

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Nature, 2018, 560(7718):372-376

PubMed: 30046109 ( click the link to review the publication )

Nature, 2017, 543(7647):728-732

PubMed: 28321130 ( click the link to review the publication )

Cancer Cell, 2017, 31(3):424-435

PubMed: 28292440 ( click the link to review the publication )

Nat Med, 2015, 10.1038/nm.3855

PubMed: 25939062 ( click the link to review the publication )

Nature, 2014, 30;514(7524):628-32.

PubMed: 25119024 ( click the link to review the publication )

Nature, 2012, 26;487(7408):505-9.

PubMed: 22763448 ( click the link to review the publication )

Cell, 2012, 13;149(2):307-21.

PubMed: 22500798 ( click the link to review the publication )

Cancer Cell, 2012, 21(2):155-67

PubMed: 22340590 ( click the link to review the publication )

Nat Microbiol, 2020, 10.1038/s41564-020-0782-1

PubMed: 32895527 ( click the link to review the publication )

Nat Commun, 2020, 14;11(1):1825

PubMed: 32286280 ( click the link to review the publication )

Genome Med, 2020, 18;12(1):17

PubMed: 32070411 ( click the link to review the publication )

Biomaterials, 2020, 246:120012

PubMed: 32276198 ( click the link to review the publication )

Theranostics, 2020, 16;10(14):6448-6466

PubMed: 32483463 ( click the link to review the publication )

Cell Rep, 2020, 32(12):108171

PubMed: 32966799 ( click the link to review the publication )

Eur J Cancer, 2020, 144:17-30

PubMed: 33316635 ( click the link to review the publication )

Oncogene, 2020, 10.1038/s41388-020-1255-y

PubMed: 32157217 ( click the link to review the publication )

Oncogene, 2020, 10.1038/s41388-020-01453-2

PubMed: 32917954 ( click the link to review the publication )

Cancers (Basel), 2020, 12(10)E3058

PubMed: 33092134 ( click the link to review the publication )

Cancers (Basel), 2020, 12(11)E3172

PubMed: 33126775 ( click the link to review the publication )

Cancers (Basel), 2020, 12(12)E3689

PubMed: 33316942 ( click the link to review the publication )

Cancers (Basel), 2020, 12(2)

PubMed: 32085396 ( click the link to review the publication )
Cell Death Dis, 2020, 29;11(5):406

PubMed: 32471991 ( click the link to review the publication )

Bioinformatics, 2020, btaa858

PubMed: 33067636 ( click the link to review the publication )

Mol Cancer Ther, 2020, 19(2):479-489

PubMed: 31672764 ( click the link to review the publication )

Mol Cancer Ther, 2020, 5;molcanther.1131.2019

PubMed: 32371585 ( click the link to review the publication )

Mol Cancer Ther, 2020, 10.1158/1535-7163.MCT-19-1017

PubMed: 32847978 ( click the link to review the publication )

Mol Oncol, 2020, 10.1002/1878-0261.12888

PubMed: 33338300 ( click the link to review the publication )

J Cancer, 2020, 11(9):2552-2559

PubMed: 32201525 ( click the link to review the publication )

Front Cell Neurosci, 2020, 15;14:134

PubMed: 32477073 ( click the link to review the publication )

Int J Mol Sci, 2020, 21(23)E9240

PubMed: 33287446 ( click the link to review the publication )

Int J Mol Sci, 2020,

PubMed: 32708306 ( click the link to review the publication )

Int J Mol Sci, 2020, 21(20)E7649

PubMed: 33081092 ( click the link to review the publication )

Int J Mol Sci, 2020, 18;21(8):2825

PubMed: 32325639 ( click the link to review the publication )

Sci Rep, 2020, 10(1):15837

PubMed: 32985581 ( click the link to review the publication )

Sci Rep, 2020, 10(1):218

PubMed: 31937834 ( click the link to review the publication )

BMC Cancer, 2020, 20(1):4

PubMed: 31898540 ( click the link to review the publication )

Cancer Med, 2020, 10.1002/cam4.3432

PubMed: 32976685 ( click the link to review the publication )

G3 (Bethesda), 2020, 4;10(5):1585-1597

PubMed: 32265286 ( click the link to review the publication )

Mol Biol Rep, 2020, 47(3):2217-2230

PubMed: 32088816 ( click the link to review the publication )

Oncol Lett, 2020, 20(6):326

PubMed: 33123242 ( click the link to review the publication )

J BUON, 2020, 020;25(1):464-471

PubMed: 32277670 ( click the link to review the publication )

Nanoscale Res Lett, 2020, 15(1):63

PubMed: 32219609 ( click the link to review the publication )

J Cancer Res Clin Oncol, 2020, 146(2):329-342

PubMed: 31912229 ( click the link to review the publication )

Am J Cancer Res, 2020, 10(6):1900-1918

PubMed: 32642299 ( click the link to review the publication )

Breast Cancer Res, 2020, 22(1):84

PubMed: 32771039 ( click the link to review the publication )
Can J Physiol Pharmacol, 2020, 10.1139/cjpp-2020-0280

PubMed: 32893666 ( click the link to review the publication )

Commun Biol, 2020, 3(1):593

PubMed: 33087841 ( click the link to review the publication )

J Cell Physiol, 2020, 10.1002/jcp.29926

PubMed: 32654229 ( click the link to review the publication )

bioRxiv, 2020, 2020/9/20.4.7.30734

PubMed: 32511305 ( click the link to review the publication )

Commun Biol, 2020, 3(1):524

PubMed: 32963283 ( click the link to review the publication )

Biochem Genet, 2020, 10.1007/s10528-020-09982-x

PubMed: 32671511 ( click the link to review the publication )

Elife, 2020, 9:e53367

PubMed: 32513387 ( click the link to review the publication )

Clin Cancer Res, 2020, 10.1158/1078-0432.CCR-19-4245

PubMed: 32605911 ( click the link to review the publication )

Biomaterials, 2020, 230:119618

PubMed: 31757530 ( click the link to review the publication )

Cell Oncol (Dordr), 2020, 43(2):223-235

PubMed: 31776938 ( click the link to review the publication )

Sci Rep, 2020, 10(1):11487

PubMed: 32661241 ( click the link to review the publication )

Cell Rep, 2020, 32(3):107933

PubMed: 32697996 ( click the link to review the publication )

Cancer Cell, 2020, 38(6):872-890.e6

PubMed: 33217342 ( click the link to review the publication )

Neoplasia, 2020, 22(10):470-483

PubMed: 32818841 ( click the link to review the publication )

Clin Transl Med, 2020, 9(1):22

PubMed: 32112175 ( click the link to review the publication )

Anim Biotechnol, 2020, 1-13

PubMed: 32657254 ( click the link to review the publication )

Gastroenterology, 2019, 10.1053/j.gastro.2019.11.013

PubMed: 31734182 ( click the link to review the publication )

Nat Chem Biol, 2019, 15(3):232-240

PubMed: 30692684 ( click the link to review the publication )

Cancer Res, 2019, 79(1):209-219

PubMed: 30389701 ( click the link to review the publication )

Cell Rep, 2019, 27(3):820-834

PubMed: 30995479 ( click the link to review the publication )

Cell Rep, 2019, 26(3):608-623

PubMed: 30650355 ( click the link to review the publication )

Cell Death Differ, 2019, 26(9):1670-1687

PubMed: 30683918 ( click the link to review the publication )

Cell Death Differ, 2019, 26(3):548-564

PubMed: 30050055 ( click the link to review the publication )

Radiology, 2019, 10.1148/radiol.2019190115

PubMed: 31335281 ( click the link to review the publication )
Oncogene, 2019, 38(15):2690-2705

PubMed: 30538293 ( click the link to review the publication )

J Pathol, 2019, 10.1002/path.5277

PubMed: 30957234 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):282

PubMed: 31262325 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):481

PubMed: 31801598 ( click the link to review the publication )

Clin Cancer Res, 2019, 25(13):4063-4078

PubMed: 30952635 ( click the link to review the publication )

Cancers, 2019, 11(2)

PubMed: 30813295 ( click the link to review the publication )

Cancers, 2019, 11(5)

PubMed: 31121848 ( click the link to review the publication )

Biomacromolecules, 2019, 20(9):3313-3323

PubMed: 31198025 ( click the link to review the publication )

J Dent Res, 2019, 98(3):304-312

PubMed: 30513244 ( click the link to review the publication )

Mol Cancer Ther, 2019, 10.1158/1535-7163

PubMed: 31289138 ( click the link to review the publication )

Front Oncol, 2019, 9:463

PubMed: 31214505 ( click the link to review the publication )

Biochem Pharmacol, 2019, 169:113640

PubMed: 31536726 ( click the link to review the publication )

Sci Rep, 2019, 9(1):1897

PubMed: 30760778 ( click the link to review the publication )

Sci Rep, 2019, 9(1):5309

PubMed: 30926929 ( click the link to review the publication )

J Cancer, 2019, 10(5):1197-1208

PubMed: 30854129 ( click the link to review the publication )

Am J Cancer Res, 2019, 9(1):145-159

PubMed: 30755818 ( click the link to review the publication )

Cancer Cell Int, 2019, 19:336

PubMed: 31871431 ( click the link to review the publication )

J Cell Physiol, 2019, 234(10):18249-18261

PubMed: 30851074 ( click the link to review the publication )

Cancer Manag Res, 2019, 11:7933-7951

PubMed: 31686909 ( click the link to review the publication )

Am J Physiol Heart Circ Physiol, 2019, 316(1):H61-H69

PubMed: 30359076 ( click the link to review the publication )

Acta Pharmacol Sin, 2019, 40(2):268-278

PubMed: 29777202 ( click the link to review the publication )

Invest Ophthalmol Vis Sci, 2019, 60(7):2764-2772

PubMed: 31247083 ( click the link to review the publication )

BMC Cancer, 2019, 20(1):1

PubMed: 31892356 ( click the link to review the publication )

Am J Transl Res, 2019, 11(10):6534-6543

PubMed: 31737204 ( click the link to review the publication )
Am J Transl Res, 2019, 11(12):7255-7271

PubMed: 31934276 ( click the link to review the publication )

Transl Oncol, 2019, 12(3):404-416

PubMed: 30550927 ( click the link to review the publication )

Am J Transl Res, 2019, 11(1):87-105

PubMed: 30787971 ( click the link to review the publication )

Oncol Rep, 2019, 10.3892/or.2019.7265

PubMed: 31524277 ( click the link to review the publication )

Int J Mol Med, 2019, 43(1):47-56

PubMed: 30387804 ( click the link to review the publication )

PLoS One, 2019, 14(5):e0216603

PubMed: 31100067 ( click the link to review the publication )

Reprod Sci, 2019, 1933719119828067

PubMed: 30791863 ( click the link to review the publication )

Vet Comp Oncol, 2019, 10.1111/vco.12490

PubMed: 31069942 ( click the link to review the publication )

Pharm Biol, 2019, 57(1):412-423

PubMed: 31230505 ( click the link to review the publication )

Oncol Lett, 2019, 18(6):6249-6260

PubMed: 31788102 ( click the link to review the publication )

Anticancer Res, 2019, 39(7):3745-3755

PubMed: 31262901 ( click the link to review the publication )

Ren Fail, 2019, 41(1):267-277

PubMed: 30982374 ( click the link to review the publication )

Exp Ther Med, 2019, 18(3):2278-2284

PubMed: 31410178 ( click the link to review the publication )

Assay Drug Dev Technol, 2019, 17(3):140-149

PubMed: 30958703 ( click the link to review the publication )

Nagoya J Med Sci, 2019, 81(1):93-102

PubMed: 30962658 ( click the link to review the publication )

Cancer Biol Med, 2019, 16(1):66-83

PubMed: 31119047 ( click the link to review the publication )

Viruses, 2019, 11(3)

PubMed: 30875748 ( click the link to review the publication )

Mol Ther Nucleic Acids, 2019, 14:287-300

PubMed: 30654190 ( click the link to review the publication )

ACS Pharmacol Transl Sci, 2019,

PubMed: 32259061 ( click the link to review the publication )

EMBO Mol Med, 2018, 10(9)

PubMed: 30108112 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(20):5165-5177

PubMed: 29941485 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2018,

PubMed: 30224486 ( click the link to review the publication )

Cancer Res, 2018, 78(9):2383-2395

PubMed: 29440171 ( click the link to review the publication )

Cancer Res, 2018, 78(13):3645-3658

PubMed: 29760043 ( click the link to review the publication )
Cancer Res, 2018, 78(15):4396-4410

PubMed: 29844118 ( click the link to review the publication )

Radiology, 2018, 288(3):730-738

PubMed: 29737948 ( click the link to review the publication )

J Invest Dermatol, 2018, 138(11):2377-2387

PubMed: 29758280 ( click the link to review the publication )

J Pathol, 2018, 245(1):101-113

PubMed: 29443392 ( click the link to review the publication )

Cancers (Basel), 2018, 10(12)

PubMed: 30563275 ( click the link to review the publication )

Cancers, 2018, 10(2)

PubMed: 29370086 ( click the link to review the publication )

Cell Death Dis, 2018, 9(2):123

PubMed: 29374144 ( click the link to review the publication )

Cell Death Dis, 2018, 9(2):45

PubMed: 29352118 ( click the link to review the publication )

J Cancer, 2018, 9(6):987-997

PubMed: 29581778 ( click the link to review the publication )

Glia, 2018, 66(5):999-1015

PubMed: 29392777 ( click the link to review the publication )

Exp Mol Med, 2018, 50(3):e463

PubMed: 29869624 ( click the link to review the publication )

Radiat Oncol, 2018, 13(1):76

PubMed: 29685176 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(2):347-354

PubMed: 28958992 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(4):599-609

PubMed: 29330285 ( click the link to review the publication )

Front Oncol, 2018, 8:249

PubMed: 30013951 ( click the link to review the publication )

Antiviral Res, 2018, 153:39-48

PubMed: 29425831 ( click the link to review the publication )

Biochem Pharmacol, 2018, 10.1016/j.bcp.2018.10.011

PubMed: 30342021 ( click the link to review the publication )

J Proteome Res, 2018, 17(1):63-75

PubMed: 29164889 ( click the link to review the publication )

Acta Pharmacol Sin, 2018, 40(2):268-278

PubMed: 29777202 ( click the link to review the publication )

Invest New Drugs, 2018, 10.1007/s10637-018-0698-2

PubMed: 30456603 ( click the link to review the publication )

Int J Hyperthermia, 2018, 34(6):812-823

PubMed: 28954551 ( click the link to review the publication )

Cancer Med, 2018, 7(9):4744-4754

PubMed: 30109783 ( click the link to review the publication )

Am J Transl Res, 2018, 10(12):4376-4384

PubMed: 30662679 ( click the link to review the publication )

Oncol Rep, 2018, 39(2):711-720

PubMed: 29207150 ( click the link to review the publication )
Oncol Rep, 2018, 40(4):2353-2362

PubMed: 30066933 ( click the link to review the publication )

Oncol Rep, 2018, 39(4):1731-1738

PubMed: 29393465 ( click the link to review the publication )

J Cell Biochem, 2018, 119(3):2708-2718

PubMed: 29057547 ( click the link to review the publication )

Int J Mol Med, 2018, 41(5):2461-2472

PubMed: 29436587 ( click the link to review the publication )

Int J Mol Med, 2018, 41(5):2755-2763

PubMed: 29436606 ( click the link to review the publication )

PLoS One, 2018, 13(2):e0191890

PubMed: 29389967 ( click the link to review the publication )

PLoS One, 2018, 13(1):e0190854

PubMed: 29357370 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 507(1-4):311-318

PubMed: 30466782 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 495(2):2004-2009

PubMed: 29253572 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 504(4):721-726

PubMed: 30217442 ( click the link to review the publication )

Anticancer Res, 2018, 38(3):1407-1414

PubMed: 29491065 ( click the link to review the publication )

Pathol Res Pract, 2018, 214(6):889-895

PubMed: 29653746 ( click the link to review the publication )

Oncol Lett, 2018, 15(6):9655-9662

PubMed: 29928341 ( click the link to review the publication )

Oncotarget, 2018, 9(6):7023-7035

PubMed: 29467947 ( click the link to review the publication )

Sci Rep, 2018, 8(1):1652

PubMed: 29374181 ( click the link to review the publication )

Oncotarget, 2018, 9(12):10483-10496

PubMed: 29535821 ( click the link to review the publication )

Discov Med, 2018, 25(140):265-275

PubMed: 30021100 ( click the link to review the publication )

Mol Cell, 2017, 65(6):999-1013

PubMed: 28306514 ( click the link to review the publication )

Nat Commun, 2017, 8(1):1636

PubMed: 29158506 ( click the link to review the publication )

Nat Commun, 2017, 8(1):1278

PubMed: 29097657 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(5):1274-1285

PubMed: 28232476 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3045-3052

PubMed: 28007777 ( click the link to review the publication )

Leukemia, 2017, 31(4):922-933

PubMed: 27686868 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2017, 114(7):E1072-E1080

PubMed: 28137841 ( click the link to review the publication )
Cell Syst, 2017,

PubMed: 28017544 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(5):1286-1298

PubMed: 27553832 ( click the link to review the publication )

J Hematol Oncol, 2017, 10(1):9

PubMed: 28061880 ( click the link to review the publication )

Cancer Lett, 2017, 388:12-20

PubMed: 27894954 ( click the link to review the publication )

Cancer Lett, 2017, 406:1-11

PubMed: 28774796 ( click the link to review the publication )

Sci Signal, 2017, 10(507)eaam7550

PubMed: 29184034 ( click the link to review the publication )

J Med Chem, 2017,

PubMed: 28471660 ( click the link to review the publication )

Cell Physiol Biochem, 2017, 43(5):1813-1828

PubMed: 29065414 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(4):729-738

PubMed: 28119490 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(9):1779-1790

PubMed: 28619753 ( click the link to review the publication )

Mol Oncol, 2017, 11(9):1130-1142

PubMed: 28544747 ( click the link to review the publication )

J Nutr Biochem, 2017, 41:124-136

PubMed: 28092744 ( click the link to review the publication )

J Cell Mol Med, 2017, 21(3):467-474

PubMed: 27680680 ( click the link to review the publication )

Sci Rep, 2017, 7(1):10612

PubMed: 28878291 ( click the link to review the publication )

Sci Rep, 2017, 7(1):12406

PubMed: 28963527 ( click the link to review the publication )

Mol Imaging Biol, 2017, 19(3):421-428

PubMed: 27770401 ( click the link to review the publication )

Acta Pharmacol Sin, 2017, 38(3):382-391

PubMed: 28042875 ( click the link to review the publication )

Mol Cell Neurosci, 2017, 82:66-75

PubMed: 28461220 ( click the link to review the publication )

Cell Cycle, 2017, 16(24):2386-2395

PubMed: 28980866 ( click the link to review the publication )

World J Gastroenterol, 2017, 23(42):7551-7562

PubMed: 29204055 ( click the link to review the publication )

Drug Des Devel Ther, 2017, 11:1115-1126

PubMed: 28435223 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 491(1):209-216

PubMed: 28712871 ( click the link to review the publication )

SLAS Discov, 2017, 22(5):507-515

PubMed: 28324660 ( click the link to review the publication )

Oncol Lett, 2017, 14(6):7970-7976

PubMed: 29250185 ( click the link to review the publication )
Onco Targets Ther, 2017, 10:5077-5087

PubMed: 29118584 ( click the link to review the publication )

Oncotarget, 2017, 8(11):17995-18009

PubMed: 28152508 ( click the link to review the publication )

Oncotarget, 2017, 8(33):53968-53977

PubMed: 28903316 ( click the link to review the publication )

Oncotarget, 2017, 8(64):107977-107990

PubMed: 29296217 ( click the link to review the publication )

Oncotarget, 2017, 8(5):7878-7890

PubMed: 28002802 ( click the link to review the publication )

Oncotarget, 2017, 8(7):11937-11949

PubMed: 28060760 ( click the link to review the publication )

Cell Cycle, 2017, 16(21):2146-2155

PubMed: 28910567 ( click the link to review the publication )

Oncotarget, 2017, 8(30):49380-49394

PubMed: 28537902 ( click the link to review the publication )

Oncotarget, 2017, 8(63):106486-106498

PubMed: 29290965 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2017, 114(6):E980-E989

PubMed: 28049849 ( click the link to review the publication )

Nano Lett, 2017, 17(11):7160-7168

PubMed: 29035540 ( click the link to review the publication )

Oncotarget, 2017, 8(5):7265-7275

PubMed: 27980219 ( click the link to review the publication )

Nat Commun, 2016, 7:11971

PubMed: 27321283 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

EMBO J, 2016, 35(20):2192-2212

PubMed: 27625374 ( click the link to review the publication )

Clin Cancer Res, 2016, 22(11):2744-54

PubMed: 26712685 ( click the link to review the publication )

J Exp Clin Cancer Res, 2016, 35:52

PubMed: 27009084 ( click the link to review the publication )

Pigment Cell Melanoma Res, 2016, 29(6):643-655

PubMed: 27463366 ( click the link to review the publication )

Mol Oncol, 2016, 10(1):101-12

PubMed: 26471831 ( click the link to review the publication )

Mol Pharm, 2016, 13(11):3724-3735

PubMed: 27653969 ( click the link to review the publication )

Sci Rep, 2016,

PubMed: 27849011 ( click the link to review the publication )

J Proteome Res, 2016, 15(12):4490-4504

PubMed: 27794612 ( click the link to review the publication )

Mol Carcinog, 2016, 55(12):2135-2155

PubMed: 26764221 ( click the link to review the publication )

Int J Oncol, 2016, 49(1):285-93

PubMed: 27176231 ( click the link to review the publication )
Biomed Pharmacother, 2016, 77:161-6

PubMed: 26796280 ( click the link to review the publication )

BMC Cancer, 2016, 16:657

PubMed: 27542970 ( click the link to review the publication )

Int J Biochem Cell Biol, 2016, 79:393-400

PubMed: 27620077 ( click the link to review the publication )

Cancer Med, 2016, 5(10):2953-2964

PubMed: 27539383 ( click the link to review the publication )

Transl Oncol, 2016, 9(3):197-202

PubMed: 27267837 ( click the link to review the publication )

Biol Chem, 2016, 397(7):671-8

PubMed: 26910743 ( click the link to review the publication )

PLoS ONE, 2016,

PubMed: 26962861 ( click the link to review the publication )

PLoS One, 2016, 11(9):e0162634

PubMed: 27611696 ( click the link to review the publication )

Thorac Cancer, 2016, 7(3):279-87

PubMed: 27148412 ( click the link to review the publication )

Cell Biochem Funct, 2016, 34(2):69-81

PubMed: 26919061 ( click the link to review the publication )

Animal, 2016, 10(8):1319-27

PubMed: 26956906 ( click the link to review the publication )

Anticancer Res, 2016, 36(4):1673-82

PubMed: 27069145 ( click the link to review the publication )

Target Oncol, 2016, 11(2):209-27

PubMed: 26453055 ( click the link to review the publication )

Oncotarget, 2016, 7(40):65627-65642

PubMed: 27582537 ( click the link to review the publication )

Oncotarget, 2016, 7(44):71211-71222

PubMed: 27655717 ( click the link to review the publication )

Tumour Biol, 2016, 37(1):419-24

PubMed: 26219899 ( click the link to review the publication )

Heliyon, 2016, 2(11):e00194

PubMed: 27896318 ( click the link to review the publication )

Oncotarget, 2016, 8(32):52193-52210

PubMed: 28881723 ( click the link to review the publication )

Oncotarget, 2016, 7(15):19214-27

PubMed: 27036037 ( click the link to review the publication )

Oncotarget, 2016, 7(40):65147-65156

PubMed: 27556501 ( click the link to review the publication )

Oncotarget, 2016, 7(4):3947-65

PubMed: 26678033 ( click the link to review the publication )

Oncotarget, 2016, 7(12):13797-809

PubMed: 26883194 ( click the link to review the publication )

J Clin Invest, 2015, 125(3):1174-88

PubMed: 25664849 ( click the link to review the publication )

Clin Cancer Res, 2015, 21(24):5499-5510

PubMed: 26272063 ( click the link to review the publication )
Leukemia, 2015, 29(4):828-38

PubMed: 25322685 ( click the link to review the publication )

Cancer Res, 2015, 75(24):5318-28

PubMed: 26670562 ( click the link to review the publication )

Elife, 2015,

PubMed: 25686219 ( click the link to review the publication )

Oncogene, 2015, 10.1038/onc.2014.444

PubMed: 25619831 ( click the link to review the publication )

Oncogene, 2015, 10.1038/onc.2015.143

PubMed: 25961924 ( click the link to review the publication )

EBioMedicine, 2015, 2(12):1944-56

PubMed: 26844273 ( click the link to review the publication )

Cancer Lett, 2015, 367(1):58-68

PubMed: 26188279 ( click the link to review the publication )

Cancer Lett, 2015, 359(1):47-56

PubMed: ( click the link to review the publication )

Breast Cancer Res, 2015, 17:32

PubMed: 25849721 ( click the link to review the publication )

J Neurosci, 2015, 35(9):3893-902

PubMed: 25740518 ( click the link to review the publication )

Cancer Discov, 2015, 5(12):1262-70

PubMed: 26370156 ( click the link to review the publication )

Mol Cancer Ther, 2015, 14(4):1014-23

PubMed: 25673820 ( click the link to review the publication )

Neoplasia, 2015, 17(1):16-31

PubMed: 25622896 ( click the link to review the publication )

Cancer Sci, 2015,

PubMed: 25483727 ( click the link to review the publication )

Am J Cancer Res, 2015, 5(5):1649-64

PubMed: 26175935 ( click the link to review the publication )

Gynecol Oncol, 2015, 139(1):118-26

PubMed: 26232337 ( click the link to review the publication )

Gynecol Oncol, 2015, 138(1):165-73

PubMed: 25933683 ( click the link to review the publication )

J Biol Chem, 2015, 290(28):17495-504

PubMed: 26023239 ( click the link to review the publication )

Cancer Cell Int, 2015, 15:65

PubMed: 26130968 ( click the link to review the publication )

J Dermatol Sci, 2015, 78(1):44-50

PubMed: 25726712 ( click the link to review the publication )

Mol Imaging Biol, 2015, 17(3):403-12

PubMed: 25465391 ( click the link to review the publication )

Cancer Biol Ther, 2015, 16(4):580-8

PubMed: 25793663 ( click the link to review the publication )

Prostate, 2015, 75(15):1747-59

PubMed: 26250606 ( click the link to review the publication )

BMC Cancer, 2015, 15:894

PubMed: 26560145 ( click the link to review the publication )
BMC Cancer, 2015,

PubMed: 26205886 ( click the link to review the publication )

Open Biol, 2015, 5(3)

PubMed: 25761368 ( click the link to review the publication )

PLoS ONE, 2015,

PubMed: 26270481 ( click the link to review the publication )

PLoS One, 2015, 10(12):e0144708

PubMed: 26678268 ( click the link to review the publication )

PLoS One, 2015, 10(4):e0123410

PubMed: 25844720 ( click the link to review the publication )

Onco Targets Ther, 2015, 8:269-77

PubMed: 25674002 ( click the link to review the publication )

Biomed Res Int, 2015, 2015:870918

PubMed: 26557706 ( click the link to review the publication )

Biomarkers, 2015,

PubMed: 26329528 ( click the link to review the publication )

Anticancer Res, 2015,

PubMed: 26637878 ( click the link to review the publication )

ACS Chem Biol, 2015, 10(10):2193-8

PubMed: 26270491 ( click the link to review the publication )

Cytometry A, 2015, 10.1002/cyto.a.22628

PubMed: 25598437 ( click the link to review the publication )

Oncotarget, 2015, 6(18):15814-27

PubMed: 26158412 ( click the link to review the publication )

Oncotarget, 2015, 6(32):32930-43

PubMed: 26431379 ( click the link to review the publication )

EJNMMI Res, 2015, 5(1):61

PubMed: 26543028 ( click the link to review the publication )

Oncotarget, 2015, 6(7):5118-33

PubMed: 25742786 ( click the link to review the publication )

Nano Lett, 2015, 15(12):8032-43

PubMed: 26540670 ( click the link to review the publication )

Oncotarget, 2015,

PubMed: 25999352 ( click the link to review the publication )

Clin Cancer Res, 2014, 20(2):404-12

PubMed: 24192926 ( click the link to review the publication )

Clin Cancer Res, 2014, 20(8):2126-35

PubMed: 24573549 ( click the link to review the publication )

Clin Cancer Res, 2014, 20(5):1235-48

PubMed: 24366691 ( click the link to review the publication )

Cancer Res, 2014, 74(10):2846-56

PubMed: 24614082 ( click the link to review the publication )

Cancer Lett, 2014, 348(1-2):38-49

PubMed: 24650799 ( click the link to review the publication )

Cancer Lett, 2014, 10.1016/j.canlet.2014.12.034

PubMed: 25554016 ( click the link to review the publication )

Breast Cancer Res, 2014, 16(4):406

PubMed: 25103565 ( click the link to review the publication )
Pigment Cell Melanoma Res, 2014, 10.1111/pcmr.12268

PubMed: 24890688 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1445

PubMed: 25299770 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1434

PubMed: 25275595 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1013

PubMed: 24457957 ( click the link to review the publication )

FASEB J, 2014, fj.13-247924

PubMed: 24903273 ( click the link to review the publication )

Mol Oncol, 2014, 8(3):544-54

PubMed: 24476679 ( click the link to review the publication )

Am J Cancer Res, 2014,

PubMed: 25520871 ( click the link to review the publication )

J Virol, 2014, 88(9):5152-64

PubMed: 24574393 ( click the link to review the publication )

Magnet Reson Med, 2014, 71(6):1973-81

PubMed: 23878023 ( click the link to review the publication )

J Biol Chem, 2014, 289(33):22785-97

PubMed: 24982421 ( click the link to review the publication )

Apoptosis, 2014, 19(5):895-904

PubMed: 24652480 ( click the link to review the publication )

Endocrinology, 2014, 155(4):1510-9

PubMed: 24476133 ( click the link to review the publication )

Expert Opin Inv Drugs, 2014, 23(4):469-87

PubMed: 24490883 ( click the link to review the publication )

Mol Cell Biol, 2014, 34(13):2517-32

PubMed: 24777602 ( click the link to review the publication )

Invest New Drugs, 2014, 32(6):1134-43

PubMed: 25152245 ( click the link to review the publication )

Anal Bioanal Chem, 2014, 406(15):3743-54

PubMed: 24817345 ( click the link to review the publication )

BMC Cancer, 2014, 14:283

PubMed: 24758408 ( click the link to review the publication )

Eur J Pharmacol, 2014, 741:195-204

PubMed: 25160744 ( click the link to review the publication )

Drug Des Devel Ther, 2014, 8:255-62

PubMed: 24600206 ( click the link to review the publication )

PLoS One, 2014, 9(10):e111146

PubMed: 25343454 ( click the link to review the publication )

PLoS One, 2014, 9(2):e88587

PubMed: 24523919 ( click the link to review the publication )

PLoS One, 2014, 9(9):e105919

PubMed: 25221930 ( click the link to review the publication )

PLoS One, 2014, 9(8):e105280

PubMed: 25144531 ( click the link to review the publication )

PLoS One, 2014, 9(9):e108193

PubMed: 25247710 ( click the link to review the publication )
Biochem Biophys Res Commun, 2014, 455(3-4):256-61

PubMed: 25449280 ( click the link to review the publication )

Biochem Biophy Res Co, 2014, 10.1016/j.bbrc.2014.11.002

PubMed: ( click the link to review the publication )

Cardiovasc Inter Rad, 2014, 37(5):1343-51

PubMed: 24452318 ( click the link to review the publication )

Oncotarget, 2014,

PubMed: 25277205 ( click the link to review the publication )

Eur Biophys J, 2014, 9(4):e95243

PubMed: 24743578 ( click the link to review the publication )

Oncotarget, 2014, 5(18):8737-49

PubMed: 25228590 ( click the link to review the publication )

Oncotarget, 2014, 5(17):7328-41

PubMed: 25193862 ( click the link to review the publication )

Oncotarget, 2014, 5(24):12862-76

PubMed: 25404640 ( click the link to review the publication )

Head Neck, 2014, 10.1002/hed.23822

PubMed: 24986420 ( click the link to review the publication )

Nat Chem Biol, 2013, 9(11):708-14

PubMed: 24013279 ( click the link to review the publication )

Clin Cancer Res, 2013, 19(19):5413-22

PubMed: 23888070 ( click the link to review the publication )

Cancer Res, 2013, 73(11):3402-11

PubMed: 23585456 ( click the link to review the publication )

Cell Death Differ, 2013, 21(3):491-502

PubMed: 24362439 ( click the link to review the publication )

Int J Cancer, 2013, 133(2):505-13

PubMed: 23319394 ( click the link to review the publication )

Int J Cancer, 2013, 133(9):2089-101

PubMed: 23629727 ( click the link to review the publication )

Oncogene, 2013, 32(17):2179-88

PubMed: 22689062 ( click the link to review the publication )

Cancer Lett, 2013, 329(2):236-42

PubMed: 23200669 ( click the link to review the publication )

Sci Signal, 2013, 6(271):ra25

PubMed: 23592840 ( click the link to review the publication )

Sci Signal, 2013,

PubMed: 23532334 ( click the link to review the publication )

Breast Cancer Res, 2013, 15(1):R16

PubMed: 23448424 ( click the link to review the publication )

Pigment Cell Melanoma Res, 2013, 26(4):518-26

PubMed: 23582185 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e827

PubMed: 24091670 ( click the link to review the publication )

Exp Mol Med, 2013, 45:e64

PubMed: 24263233 ( click the link to review the publication )

J Mater Chem B, 2013, 5602-5610

PubMed: ( click the link to review the publication )
Cancer Sci, 2013, 104(7):896-903

PubMed: 23578175 ( click the link to review the publication )

Mol Cancer Res, 2013, 11(10):1269-78

PubMed: 23814023 ( click the link to review the publication )

Magn Reson Med, 2013, 71(6):1973-81

PubMed: 23878023 ( click the link to review the publication )

J Biol Chem, 2013, 288(42):30387-98

PubMed: 24014036 ( click the link to review the publication )

Acta Pharmacol Sin, 2013, 34(5):681-90

PubMed: 23603977 ( click the link to review the publication )

Transl Oncol, 2013, 6(5):586-95

PubMed: 24151539 ( click the link to review the publication )

Cancer Chemother Pharmacol, 2013, 71(5):1297-307

PubMed: 23479136 ( click the link to review the publication )

PLoS One, 2013, 8(3):e59879

PubMed: 23533654 ( click the link to review the publication )

J Biomol Screen, 2013, 19(1):131-44

PubMed: 23954931 ( click the link to review the publication )

J Thorac Oncol, 2012, 7(2):272-80

PubMed: 22089117 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(9):2515-25

PubMed: 22392911 ( click the link to review the publication )

Eur J Cancer, 2012, 48(6):936-43

PubMed: 22088482 ( click the link to review the publication )

Oncogene, 2012, 33(2):236-45

PubMed: 23246970 ( click the link to review the publication )

J Invest Dermatol, 2012, 132(7):1850-9

PubMed: 22437314 ( click the link to review the publication )

Sci Signal, 2012, 5(224):rs4

PubMed: 22589389 ( click the link to review the publication )

J Neurosci, 2012, 32(1):264-74

PubMed: 22219288 ( click the link to review the publication )

Neoplasia, 2012, 14(1):34-43

PubMed: 22355272 ( click the link to review the publication )

Cancer Sci, 2012, 103(11):1955-60

PubMed: 22925034 ( click the link to review the publication )

J Virol, 2012, 86(8):4578-85

PubMed: 22345463 ( click the link to review the publication )

Mol Pharmacol, 2012,

PubMed: 22989520 ( click the link to review the publication )

Mol Pharmacol, 2012, 81(5):748-58

PubMed: 22357666 ( click the link to review the publication )

Hum Pathol, 2012, 43(12):2197-206

PubMed: 22705003 ( click the link to review the publication )

J Surg Oncol, 2012, 106(8):972-80

PubMed: 22711648 ( click the link to review the publication )

PLoS One, 2012, 7(9):e46518

PubMed: 23029544 ( click the link to review the publication )
Blood, 2011, 118(14):3911-21

PubMed: 21821710 ( click the link to review the publication )

Cancer Res, 2011, 71(15):5067-74

PubMed: 21803746 ( click the link to review the publication )

Breast Cancer Res, 2011, 13(3):R52

PubMed: 21595894 ( click the link to review the publication )

Int J Proteomics, 2011, 2011:215496

PubMed: 22091388 ( click the link to review the publication )

Clin Cancer Res, 2010, 16(24):6029-39

PubMed: 21169255 ( click the link to review the publication )

Cancer Res, 2010, 70(11):4709-18

PubMed: 20484037 ( click the link to review the publication )

Cancer Res, 2010, 70(12):4982-94

PubMed: 20530683 ( click the link to review the publication )

Eur J Cancer, 2010, 46(6):1111-21

PubMed: 20129775 ( click the link to review the publication )

Biochemistry, 2010, 49(39):8488-98

PubMed: 20804212 ( click the link to review the publication )

产品安全说明书

PI3K抑制剂选择性比较

生物活性

产品描述

靶点

p110α ^[1] (Cell-free assay)	p110γ ^[1] (Cell-free assay)	mTOR (p70S6K) ^[1] (Cell-free assay)	p110δ ^[1] (Cell-free assay)	ATR ^[8] (3T3^TopBP1-ER cells)	点击更多
4 nM	5 nM	6 nM	7 nM	21 nM	点击更多

体外研究

BEZ235显著降低mTOR活化的激酶p70S6K的磷酸化水平。BEZ235导致S235/S236P-RPS6水平减少，IC50为6.5 nM。BEZ235抗mTOR的活性使用生化mTOR K-LISA试验测定，IC50为20.7 nM。BEZ235对其β旁系同源物的活性稍弱，IC50为75 nM。在人肿瘤细胞中，PI3K/Akt/mTOR通路经常被组成性活化。BEZ235阻断PI3K和mTOR激酶活性，通过结合于这些酶的ATP结合槽发挥作用。用逐渐增加浓度BEZ235处理PTEN-null细胞系PC3M和U87MG时，导致细胞增殖剂量依赖性减少，平均GI50为10-12 nM。^[1] BEZ235是一种mTORC1/2催化抑制剂。^[2]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
Trypanosoma brucei brucei	MlfVRY51cW2rY4LvZolidCCDc4PhfS=>		MkTzNVghcA>?	NGjxUplFVVOR	NH:3UnFCdnSrdIL5dIFvd3OxbXHsJIFkfGm4aYT5JJdqfGhiRVO1NEBw\iByLkCwNlUh\|ryP	MYKyOFgxPTl2Nh?=
MCF7	M1fQbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{LYbVAvODFvMUCwJO69VQ>?	Mly4OFghcA>?	M3PMcGROW09?	MYDJR\|UxRTBwN{Og{txO	MV2yN\|g4OTlyNB?=
HCT116	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M361OlAvODFvMUCwJO69VQ>?	NUHiUmlUPDhiaB?=	M1PT[2ROW09?	MWrJR\|UxRTFwMU[g{txO	M1fTdFI{QDdzOUC0
U87MG	NED3dVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{G1UlAvODFvMUCwJO69VQ>?	NFvhV4E1QCCq	NVK1RpJyTE2VTx?=	MlrrTWM2OD1zLkOyJO69VQ>?	NXThXGNbOjN6N{G5NFQ>
HBC4	M1zHU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlrwNE4xOS1zMECg{txO	NUj0cYZ6PDhiaB?=		M1\Kb2xw\yCJSUWwQU05NjZzIF2=	M1fSUVIzOzN4MkS2
BSY1	Mm\wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2TSdlAvODFvMUCwJO69VQ>?	MUG0PEBp		MoW5UI9oKEeLNUC9MVgvPDhiTR?=	MlOwNlI{OzZ{NE[=
HBC5	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVntOnFMOC5yMT2xNFAh\|ryP	M3jGXlQ5KGh?		MoHGUI9oKEeLNUC9MVcvQDdiTR?=	MYmyNlM{PjJ2Nh?=
MCF7	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NES2N5gxNjBzLUGwNEDPxE1?	M3j4clQ5KGh?		MUnMc4chT0l3ME2tPE4yPiCP	M4jPb\|IzOzN4MkS2
MDA-MB-231	MkfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnHDNE4xOS1zMECg{txO	NFHMPYI1QCCq		MVPMc4chT0l3ME2tPE4xQSCP	M1z3[FIzOzN4MkS2
U251	Mo\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MX2wMlAyNTFyMDFOwG0>	M4nWeFQ5KGh?		NYPSOJhyVG:pIFfJOVA:NTdwNk[gUS=>	MnfvNlI{OzZ{NE[=
SF268	NWj3[nFnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYWwMlAyNTFyMDFOwG0>	NV\wc3N2PDhiaB?=		NWTiOHFjVG:pIFfJOVA:NTdwOUKgUS=>	NH;oZ5ozOjN\|NkK0Oi=>
SF295	M1zvOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUKwMlAyNTFyMDFOwG0>	NV7nSnhYPDhiaB?=		NHe2PXhNd2diR1m1NF0uQC5\|MTDN	MUeyNlM{PjJ2Nh?=
SF539	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXPtV3N3OC5yMT2xNFAh\|ryP	M{LjXFQ5KGh?		Mnv3UI9oKEeLNUC9MVgvPTliTR?=	NETlN3MzOjN\|NkK0Oi=>
SNB75	NYDONGoyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXnJ[XI2OC5yMT2xNFAh\|ryP	M{P2eFQ5KGh?		Mn63UI9oKEeLNUC9MVgvPThiTR?=	MlixNlI{OzZ{NE[=
SNB78	NWez[VZnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYPZfFFDOC5yMT2xNFAh\|ryP	M{PCfFQ5KGh?		M1H5NWxw\yCJSUWwQU05NjZ3IF2=	M3K1NVIzOzN4MkS2
HCC2998	NI\NeIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NV7ON2k5OC5yMT2xNFAh\|ryP	MYS0PEBp		NE\FW4dNd2diR1m1NF0uQC5yNTDN	NH\GNYEzOjN\|NkK0Oi=>
KM12	NGLFdlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NF61SmcxNjBzLUGwNEDPxE1?	M3rmNlQ5KGh?		NHTsUJhNd2diR1m1NF0uPy53NDDN	NXS3[oFROjJ\|M{[yOFY>
HT-29	NX7kTVZNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWqwMlAyNTFyMDFOwG0>	MXu0PEBp		MorVUI9oKEeLNUC9MVcvPzViTR?=	Mn3uNlI{OzZ{NE[=
HCT15	MmntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3e2cFAvODFvMUCwJO69VQ>?	NGSzc5c1QCCq		M2qwbWxw\yCJSUWwQU05NjB\|IF2=	NF\nc48zOjN\|NkK0Oi=>
HCT116	MlvUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NInlOmgxNjBzLUGwNEDPxE1?	M3jnS\|Q5KGh?		NGPBTlNNd2diR1m1NF0uPy54MTDN	NIKySmkzOjN\|NkK0Oi=>
NCI-H23	NFe0O4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEjmfJMxNjBzLUGwNEDPxE1?	NXuxRZE6PDhiaB?=		NUDFXoU3VG:pIFfJOVA:NTdwNkSgUS=>	NHT2bpczOjN\|NkK0Oi=>
NCI-H226	NG[3V5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MUWwMlAyNTFyMDFOwG0>	NWqx[Yo5PDhiaB?=		M1rGOmxw\yCJSUWwQU05NjR2IF2=	NFm0UpYzOjN\|NkK0Oi=>
NCI-H522	M{TqeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUGwMlAyNTFyMDFOwG0>	M1LNR\|Q5KGh?		MorlUI9oKEeLNUC9MVgvPDViTR?=	MXuyNlM{PjJ2Nh?=
NCI-H438	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2DD[lAvODFvMUCwJO69VQ>?	MnnYOFghcA>?		MW\Mc4chT0l3ME2tPE4yOSCP	MmP4NlI{OzZ{NE[=
A549	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVPKcoVuOC5yMT2xNFAh\|ryP	M{myc\|Q5KGh?		NEX4Z5RNd2diR1m1NF0uQC5yNzDN	NWLxUGdUOjJ\|M{[yOFY>
DMS273	M{X1WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnvCNE4xOS1zMECg{txO	M2LMZVQ5KGh?		MX3Mc4chT0l3ME2tO{45OCCP	MkThNlI{OzZ{NE[=
DMS114	NX\RXY95T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3LPd\|AvODFvMUCwJO69VQ>?	MnLXOFghcA>?		NX7kdokzVG:pIFfJOVA:NThwM{mgUS=>	Ml3QNlI{OzZ{NE[=
LOXIMVI	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXWwMlAyNTFyMDFOwG0>	NH;rVmc1QCCq		M4TESWxw\yCJSUWwQU05NjZ4IF2=	MojmNlI{OzZ{NE[=
OVCAR3	NYfqdYNLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVnYWnR[OC5yMT2xNFAh\|ryP	MnPpOFghcA>?		M2fHWWxw\yCJSUWwQU05NjF5IF2=	NEWwdXQzOjN\|NkK0Oi=>
OVCAR4	M2Hmdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVOwMlAyNTFyMDFOwG0>	NWLIc\|N3PDhiaB?=		MXPMc4chT0l3ME2tPE42QCCP	M164OVIzOzN4MkS2
OVCAR5	NUPqd5dYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWiwMlAyNTFyMDFOwG0>	NILrbYY1QCCq		MVXMc4chT0l3ME2tO{42PyCP	M{XreFIzOzN4MkS2
OVCAR8	NGXaSHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MlnLNE4xOS1zMECg{txO	NXHKSFdwPDhiaB?=		Ml3nUI9oKEeLNUC9MVcvQDRiTR?=	NHr6[2EzOjN\|NkK0Oi=>
SKOV3	M1e5NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MV6wMlAyNTFyMDFOwG0>	MlHwOFghcA>?		M4TBeGxw\yCJSUWwQU05NjRzIF2=	MXKyNlM{PjJ2Nh?=
RXF631L	NH\LUplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHf4fZMxNjBzLUGwNEDPxE1?	NYXG[VZJPDhiaB?=		MWnMc4chT0l3ME2tPE4zOSCP	MmDXNlI{OzZ{NE[=
ACHN	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mn2wNE4xOS1zMECg{txO	Mlr5OFghcA>?		Mo[0UI9oKEeLNUC9MVcvQTViTR?=	MkXmNlI{OzZ{NE[=
St-4	NVfkToxuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHzZT3YxNjBzLUGwNEDPxE1?	NETMXJY1QCCq		NYDsXo9kVG:pIFfJOVA:NTdwNEegUS=>	NG[0V3gzOjN\|NkK0Oi=>
MKN1	NVjGeJk4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MV[wMlAyNTFyMDFOwG0>	NHG2bWo1QCCq		MYPMc4chT0l3ME2tPE41OSCP	MVGyNlM{PjJ2Nh?=
MKN7	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmfoNE4xOS1zMECg{txO	MVq0PEBp		Mn;TUI9oKEeLNUC9MVcvPjhiTR?=	M4LleFIzOzN4MkS2
MKN28	MnPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NX60VmdCOC5yMT2xNFAh\|ryP	NXTXVJRXPDhiaB?=		MY\Mc4chT0l3ME2tO{4xPyCP	M1P5SVIzOzN4MkS2
MKN45	M4rMU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1LLTFAvODFvMUCwJO69VQ>?	MW[0PEBp		M4D0c2xw\yCJSUWwQU05NjN2IF2=	NFTsRm4zOjN\|NkK0Oi=>
MKN74	M2XuVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGP6SIsxNjBzLUGwNEDPxE1?	NITpVnU1QCCq		NHTkVmhNd2diR1m1NF0uPy52MjDN	M{OxNVIzOzN4MkS2
DU145	NGfUbItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnPkNE4xOS1zMECg{txO	NHftfpE1QCCq		NVi0NIFbVG:pIFfJOVA:NThwMU[gUS=>	M4HaR\|IzOzN4MkS2
PC3	NWXsNoR1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NU\1U4djOC5yMT2xNFAh\|ryP	NXfEbXBQPDhiaB?=		NYXjS\|ZOVG:pIFfJOVA:NThwNk[gUS=>	NWDiPHczOjJ\|M{[yOFY>
Trypanosoma brucei brucei	M1;Be2Z2dmO2aX;uJGF{e2G7	NIqyc2kzODBibl2=	NXuxXXNxOTJiaB?=	MWDEUXNQ	NET3W2dF\WO{ZXHz[UBqdiCyaH;zdIhwfGmmeXygbY5we2m2b3ygdIhwe3CqYYTlJIxmfmWu	MmD3NlQ5ODV7NE[=
Trypanosoma brucei brucei	MYjGeY5kfGmxbjDBd5NigQ>?		NHfQUYUyQCCq	NYC0dINrTE2VTx?=	MXzJcohq[mm2aX;uJI9nKHKnY3XweI9zNW2nZHnheIVlKGWwZH;jfZRwe2m\|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKHS{YX7z[oVzemmwIIXweIFs\Q>?	Mlv1NlQ5ODV7NE[=
Trypanosoma brucei brucei	MneySpVv[3Srb36gRZN{[Xl?	NF72UIgzODBibl2=	MkDwNVIhcA>?	MmqxSG1UVw>?	NVryeZdoTW[oZXP0JI9vKHOyaHnu[49ugWynaX6gcIV3\Wx?	NUHmVpNjOjR6MEW5OFY>
Trypanosoma brucei brucei	M1L0O2Z2dmO2aX;uJGF{e2G7	NWm2XnlqOjByIH7N	NUL6SGdtOTJiaB?=	M{PGe2ROW09?	NUPjcHZLTW[oZXP0JI9vKHCqb4PwbIF1cWS7bHPoc4xqdmVibHX2[Yw>	MWCyOFgxPTl2Nh?=
UM-UC-3	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1Sz[mlEPTB;M{G1JJBO	M4HKZnNCVkeHUh?=
SBC-1	NWTLdnlvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkKwTWM2OD15NEKgdG0>	M3rRNXNCVkeHUh?=
MKN1	MkLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnrETWM2OD1{Lkigcm0>	NF71WmNUSU6JRWK=
NCI-H720	M2LmZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmHTTWM2OD1\|LkW3JI5O	MojhV2FPT0WU
BFTC-909	NXy0cI52T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGHMenhKSzVyPUOuO\|Ehdk1?	NV\hZ\|lLW0GQR1XS
BPH-1	Mlv2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NX3yeVBTUUN3ME20Mlc3KG6P	NIXje21USU6JRWK=
PC-3	NVH1[YJCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkW1TWM2OD13LkC5JI5O	MVnTRW5ITVJ?
AN3-CA	NGrQd3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXjJR\|UxRTVwNU[gcm0>	MVLTRW5ITVJ?
HN	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVLTWVAzUUN3ME21Mlk3KG6P	NUm3ZXM5W0GQR1XS
HCC2218	NYXSSWhXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWPS[ZZtUUN3ME22MlYyKG6P	NIj2UI5USU6JRWK=
KP-4	NUDibmZqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXnNSmlFUUN3ME23JI5O	NGnZbJBUSU6JRWK=
LU-139	MkTNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUj6eFlHUUN3ME23Mlc4KG6P	Mo[5V2FPT0WU
ETK-1	MnjwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUTJR\|UxRTdwOEigcm0>	NHnCTFZUSU6JRWK=
Ramos-2G6-4C10	M2C2eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXzJR\|UxRThwNEmgcm0>	M2nWdXNCVkeHUh?=
MHH-PREB-1	MnnvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkfrTWM2OD17LkGyJI5O	NHf2N4xUSU6JRWK=
DU-4475	NXzZ[Y93T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MofSTWM2OD17LkS0JI5O	M4[yUHNCVkeHUh?=
NCI-H1666	M2nZRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYS2RXAyUUN3ME25MlcyKG6P	M{fQT3NCVkeHUh?=
CAMA-1	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4jremlEPTB;OT64JI5O	MXvTRW5ITVJ?
TYK-nu	M1OwZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4\Xc2lEPTB;OT65OEBvVQ>?	NIixRlRUSU6JRWK=
MFE-280	NGTQTIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVT0bFdtUUN3ME25Mlk6KG6P	M{\wUXNCVkeHUh?=
A549	MoX1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXLJR\|UxRTFyLkG0JI5O	MnnEV2FPT0WU
769-P	Mne1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkWwTWM2OD1zMD60OEBvVQ>?	NInOZoxUSU6JRWK=
L-363	NVPo[ZNzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2HDVWlEPTB;MUCuOlkhdk1?	NHr2cGNUSU6JRWK=
ES8	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYrkeJZwUUN3ME2xNE46KG6P	MYHTRW5ITVJ?
PA-1	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkDkTWM2OD1zMT64NkBvVQ>?	NHXxelZUSU6JRWK=
Mewo	Ml\0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIDsTY5KSzVyPUGxMlk6KG6P	M4nadnNCVkeHUh?=
HSC-3	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2\nfGlEPTB;MUKuNlEhdk1?	NFT6VpJUSU6JRWK=
H4	MoDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYXJR\|UxRTF{Lk[3JI5O	MW\TRW5ITVJ?
BB65-RCC	MkDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3zHUGlEPTB;MUKuO\|Ihdk1?	M3nLVXNCVkeHUh?=
NCI-H1793	Mk\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV6zOXAzUUN3ME2xNk45OiCwTR?=	M4DZUHNCVkeHUh?=
KARPAS-45	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWDQcWZCUUN3ME2xN{42OSCwTR?=	MnjIV2FPT0WU
GCT	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmT3TWM2OD1zMz62PEBvVQ>?	NWDzcFNGW0GQR1XS
EoL-1	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoXiTWM2OD1zMz65N{BvVQ>?	MX3TRW5ITVJ?
LB2241-RCC	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmPqTWM2OD1zND6wNUBvVQ>?	MkPzV2FPT0WU
ES5	NGfJPI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXnJR\|UxRTF2Lke0JI5O	NF;oU5ZUSU6JRWK=
LOXIMVI	NXrlbZNDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWnad2tvUUN3ME2xOE46QSCwTR?=	NWnxcHRnW0GQR1XS
COR-L105	M1nUS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHHPV3dKSzVyPUG1MlA1KG6P	MVvTRW5ITVJ?
P12-ICHIKAWA	NX34SHhsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX7iVIRwUUN3ME2xOU4yKG6P	MmG5V2FPT0WU
CHL-1	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVSxUoxtUUN3ME2xOU41PSCwTR?=	NYjzS5VpW0GQR1XS
VMRC-RCZ	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVHJR\|UxRTF3Lk[zJI5O	M3vTdHNCVkeHUh?=
HH	NEj6V2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX7JR\|UxRTF3Lkegcm0>	NIXzc4xUSU6JRWK=
NUGC-3	M{fM[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnLWTWM2OD1zNj6zOEBvVQ>?	NFzURpVUSU6JRWK=
EGI-1	NYPHc5pWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3jJTGlEPTB;MU[uOFMhdk1?	NV3Kd4V1W0GQR1XS
OS-RC-2	Mo\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2PIc2lEPTB;MU[uOFchdk1?	M2LXSHNCVkeHUh?=
MOLT-16	M3HzPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYPJR\|UxRTF5LkG1JI5O	NFHUWHRUSU6JRWK=
NCI-H209	NV7PcZZMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVnpeFA3UUN3ME2xO{4zQSCwTR?=	MmrvV2FPT0WU
697	M1PUcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{LicGlEPTB;MUeuOFMhdk1?	NVvz[Zg2W0GQR1XS
D-56MG	NYLoZoQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYXReFF2UUN3ME2xO{43QSCwTR?=	NFfDZ3FUSU6JRWK=
VA-ES-BJ	NWH5TohCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVvSdXlSUUN3ME2xO{45OyCwTR?=	MXzTRW5ITVJ?
EW-16	NGnH[I9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVjJR\|UxRTF6LkC0JI5O	M1zpTXNCVkeHUh?=
HGC-27	Moi2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGjadZRKSzVyPUG4MlA3KG6P	MoLOV2FPT0WU
ES7	NHO2[ohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV3JR\|UxRTF6LkC5JI5O	MWnTRW5ITVJ?
HuH-7	Ml3VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVfWdWhSUUN3ME2xPE41KG6P	NUXmWno3W0GQR1XS
BCPAP	MoT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4\VVGlEPTB;MUiuOlUhdk1?	M1jsbXNCVkeHUh?=
SW1710	Mm\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3;CZWlEPTB;MUiuO\|Ihdk1?	Ml60V2FPT0WU
IST-MEL1	NUXZcVNMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXXJR\|UxRTF6Lke3JI5O	MlToV2FPT0WU
SF295	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYLRc3ZzUUN3ME2xPE46OyCwTR?=	MmrxV2FPT0WU
RPMI-7951	M4HmWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXPJR\|UxRTF7LkK4JI5O	NF3NNGVUSU6JRWK=
SF126	NHfGZphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGPxNndKSzVyPUG5MlQyKG6P	NHz3eI5USU6JRWK=
GAMG	NEjmeXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIHaS\|VKSzVyPUG5MlQ5KG6P	MUPTRW5ITVJ?
KNS-81-FD	NISxfolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXGwUVFOUUN3ME2xPU42PCCwTR?=	NVvsTY9wW0GQR1XS
RT-112	M1WxOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYPJR\|UxRTF7Lk[2JI5O	NGfIcmlUSU6JRWK=
DEL	M4LMUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVTJR\|UxRTJyLkS5JI5O	NFjHTm1USU6JRWK=
CGTH-W-1	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlrWTWM2OD1{MD62N{BvVQ>?	NUHjdoV3W0GQR1XS
HOS	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmDMTWM2OD1{MT6wOkBvVQ>?	MUDTRW5ITVJ?
ES4	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV7JR\|UxRTJzLkC4JI5O	NFT0XmlUSU6JRWK=
RXF393	MnfzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmT3TWM2OD1{MT60OUBvVQ>?	NF\ob2ZUSU6JRWK=
NCI-H2030	M3TafGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVS5N4pXUUN3ME2yNU42OiCwTR?=	MYLTRW5ITVJ?
YH-13	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3W3WGlEPTB;MkGuPFghdk1?	NFH2WZZUSU6JRWK=
HT-1080	MlrPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3;sdmlEPTB;MkGuPVMhdk1?	NXrHNJlqW0GQR1XS
NCI-SNU-1	MkXoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV7ZZXZ7UUN3ME2yNU46PSCwTR?=	NV[1ZWk{W0GQR1XS
G-402	MnS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFPQU\|VKSzVyPUKyMlE3KG6P	M2C4c3NCVkeHUh?=
786-0	M3jEPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3flbGlEPTB;MkKuNlkhdk1?	M1PxOXNCVkeHUh?=
ME-180	NGDofVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGLmXmRKSzVyPUKyMlQ{KG6P	NWLHZZNXW0GQR1XS
NB69	NHLZcGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYPpNoFIUUN3ME2yNk42OyCwTR?=	MWHTRW5ITVJ?
J-RT3-T3-5	NVfnWWZzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3TJbGlEPTB;MkKuPVYhdk1?	MV;TRW5ITVJ?
TGBC1TKB	NWLxPYF3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGr2[FRKSzVyPUKzMlA2KG6P	MVTTRW5ITVJ?
SW780	Mmq5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnH0TWM2OD1{Mz6xN{BvVQ>?	NYfqSGlTW0GQR1XS
MG-63	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHy2OXJKSzVyPUKzMlQ2KG6P	NVLGT41HW0GQR1XS
BV-173	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYnJR\|UxRTJ\|Lki3JI5O	NV:3cXZXW0GQR1XS
CAL-51	NG\uV\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHr3ZXhKSzVyPUKzMlg6KG6P	M2TTc3NCVkeHUh?=
A375	MmnnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF6yXpNKSzVyPUKzMlk{KG6P	NYrxdolQW0GQR1XS
MEL-HO	Ml3WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX7JR\|UxRTJ2LkC0JI5O	MkWyV2FPT0WU
EFO-27	NFzIS2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkHXTWM2OD1{ND6zN{BvVQ>?	NH3n[G9USU6JRWK=
Hs-578-T	MmDMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGfSc3RKSzVyPUK0MlU5KG6P	NWTCc4Q{W0GQR1XS
NBsusSR	NYm0NmZkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGDsPVlKSzVyPUK0MlYhdk1?	MoXvV2FPT0WU
CTB-1	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYnjdYtHUUN3ME2yOE43PyCwTR?=	NXXGSW9OW0GQR1XS
FTC-133	NX;pUlg1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF3OcWtKSzVyPUK1MlEhdk1?	M3m5dHNCVkeHUh?=
MOLT-4	MnrZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYXjZWQ5UUN3ME2yOU4yOiCwTR?=	MVjTRW5ITVJ?
HO-1-N-1	Mn;PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M37iZWlEPTB;MkWuNVUhdk1?	M{nQRnNCVkeHUh?=
ES3	NIe0Z2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWjJR\|UxRTJ3LkKyJI5O	MX;TRW5ITVJ?
TI-73	M1Xzdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWDJR\|UxRTJ3LkK4JI5O	Mnf5V2FPT0WU
MPP-89	NGjiTGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWnXdWNSUUN3ME2yOU4{OiCwTR?=	NUHWWJB3W0GQR1XS
KYSE-150	MlH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NELMUYNKSzVyPUK1Mlg6KG6P	NWfWTWZ1W0GQR1XS
LXF-289	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEf1UoFKSzVyPUK2MlA1KG6P	MXjTRW5ITVJ?
SK-LU-1	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFTRS3hKSzVyPUK2MlE4KG6P	MXrTRW5ITVJ?
HOP-92	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHvne2pKSzVyPUK2MlQ5KG6P	NFu3XIpUSU6JRWK=
HuO9	Ml3KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mo\ITWM2OD1{Nj63OkBvVQ>?	MYTTRW5ITVJ?
SW962	M{XVWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2DJNGlEPTB;Mk[uO\|Yhdk1?	MnvKV2FPT0WU
RS4-11	Mmi4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWDJR\|UxRTJ4LkmxJI5O	MnfOV2FPT0WU
NCI-H292	NFPRTo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnzYTWM2OD1{NzDuUS=>	NHLr[pRUSU6JRWK=
DB	NHjySFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MonLTWM2OD1{Nz6zOkBvVQ>?	MmnxV2FPT0WU
SW1088	NYDMfol[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4jy[GlEPTB;MkiuNlkhdk1?	MlnNV2FPT0WU
A204	MoPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3GwR2lEPTB;MkiuOFchdk1?	M1[3UXNCVkeHUh?=
A3-KAW	Ml7OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH7ofYxKSzVyPUK4MlY1KG6P	NUjZ[Y9tW0GQR1XS
MV-4-11	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn\GTWM2OD1{OD63JI5O	M32zeXNCVkeHUh?=
ES1	NHXJfWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX3JR\|UxRTJ6Lki0JI5O	NV7UfIpnW0GQR1XS
ONS-76	M4THfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MV3JR\|UxRTJ7LkC1JI5O	NFi3dZdUSU6JRWK=
D-263MG	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYX1WYtWUUN3ME2yPU4{PSCwTR?=	MYjTRW5ITVJ?
U-2-OS	Moj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NI\lWmJKSzVyPUK5MlUhdk1?	NGjPNYVUSU6JRWK=
T98G	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYW2emlLUUN3ME2yPU45QCCwTR?=	NITjd3dUSU6JRWK=
GI-ME-N	NFrN[JNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{XnbmlEPTB;MkmuPVEhdk1?	NFPtOZJUSU6JRWK=
BHT-101	NYeyO49GT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlrUTWM2OD1\|MD6wOUBvVQ>?	MXjTRW5ITVJ?
NOS-1	Mn:0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M33NN2lEPTB;M{CuNVIhdk1?	M3eze3NCVkeHUh?=
AsPC-1	MmLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWTJR\|UxRTNyLkKgcm0>	NX;KbGhRW0GQR1XS
QIMR-WIL	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVvJR\|UxRTNyLk[gcm0>	MUfTRW5ITVJ?
JVM-3	M3u2Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MofLTWM2OD1\|MD64N{BvVQ>?	M3rFVXNCVkeHUh?=
KU-19-19	Mn\KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1HkPWlEPTB;M{GuNVMhdk1?	M2PIUnNCVkeHUh?=
OVCAR-8	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2\wSGlEPTB;M{GuNlYhdk1?	MWnTRW5ITVJ?
BEN	MoPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2K3TWlEPTB;M{GuOlMhdk1?	MUPTRW5ITVJ?
BE-13	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1jaZmlEPTB;M{GuPFIhdk1?	M1n2S3NCVkeHUh?=
EW-18	MlPES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXLJR\|UxRTNzLki2JI5O	MWrTRW5ITVJ?
ECC10	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEjxSmNKSzVyPUOxMlk2KG6P	M{j3O3NCVkeHUh?=
CTV-1	NUPxfYxRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Ml3LTWM2OD1\|Mj64NkBvVQ>?	M13ONnNCVkeHUh?=
COLO-800	M2\sVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHPXXVFKSzVyPUOyMlkzKG6P	M2DofHNCVkeHUh?=
A2058	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn7GTWM2OD1\|Mz6yOUBvVQ>?	MkjFV2FPT0WU
VM-CUB-1	NF[xdIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml21TWM2OD1\|Mz60N{BvVQ>?	M4i2fnNCVkeHUh?=
Ca9-22	NWPuV3U1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF3KfYZKSzVyPUOzMlU2KG6P	NULqbppnW0GQR1XS
COLO-684	NYrIWWYzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTN\|LkW4JI5O	MmXBV2FPT0WU
RPMI-8226	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYXJR\|UxRTN\|LkiyJI5O	Mke3V2FPT0WU
SK-NEP-1	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUXJR\|UxRTN2LkG1JI5O	NGKzNJhUSU6JRWK=
Becker	MlHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXzJR\|UxRTN2LkKxJI5O	MnzJV2FPT0WU
NCI-H28	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXzjV\|NkUUN3ME2zOE41PCCwTR?=	Mk\hV2FPT0WU
CAL-120	M3nsTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlLiTWM2OD1\|ND63NkBvVQ>?	M1z6dnNCVkeHUh?=
MDA-MB-157	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlvnTWM2OD1\|NT60NUBvVQ>?	NXPwfVZjW0GQR1XS
OVCAR-5	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2jtUmlEPTB;M{WuOFchdk1?	Mn7LV2FPT0WU
LAMA-84	NGT6WJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MojUTWM2OD1\|NT64O{BvVQ>?	NGDFd5lUSU6JRWK=
CAKI-1	MofhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUjFUIJKUUN3ME2zOk41OyCwTR?=	M{n0SnNCVkeHUh?=
Daoy	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYTrR5pGUUN3ME2zOk44KG6P	MnLmV2FPT0WU
CAL-62	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWTJR\|UxRTN4Lki2JI5O	NGXqUYpUSU6JRWK=
8-MG-BA	NX\rW5hZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX7JR\|UxRTN5LkK1JI5O	MkfrV2FPT0WU
8505C	M{Xa[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXjFb4lEUUN3ME2zO{42OSCwTR?=	NY\VbFF6W0GQR1XS
LNCaP-Clone-FGC	Mo\VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVT0NIh[UUN3ME2zO{42QSCwTR?=	M2[4OnNCVkeHUh?=
CAL-39	MmC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlTFTWM2OD1\|Nz65JI5O	MoflV2FPT0WU
MN-60	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3rOVGlEPTB;M{euPVYhdk1?	MlfnV2FPT0WU
RKO	NEHteGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml;vTWM2OD1\|OD6zN{BvVQ>?	M3H1UXNCVkeHUh?=
U251	MoDiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MW\JR\|UxRTN6LkSzJI5O	MkjjV2FPT0WU
SJSA-1	NUOzVmZXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4W1[2lEPTB;M{iuOVQhdk1?	NWjORXptW0GQR1XS
CAL-12T	Mn;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV3JR\|UxRTN6Lk[gcm0>	MkS4V2FPT0WU
HCC1419	Ml;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWfJR\|UxRTN6LkexJI5O	NYfSUYx4W0GQR1XS
CO-314	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYjJR\|UxRTN6Lke0JI5O	MWHTRW5ITVJ?
LB1047-RCC	NVjpZmFuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MV\JR\|UxRTN6LkixJI5O	Mo\JV2FPT0WU
A101D	M1zWUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml;TTWM2OD1\|OD65O{BvVQ>?	NEj2RpNUSU6JRWK=
MDA-MB-175-VII	MkLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\yTmlKSzVyPUO5MlUyKG6P	NXfIVoF1W0GQR1XS
MZ2-MEL	NFP5NpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIH1UFhKSzVyPUO5MlY3KG6P	MYrTRW5ITVJ?
NB5	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYHwRndRUUN3ME20NE43PCCwTR?=	NV\iSok2W0GQR1XS
G-401	NGjibG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGTLWlFKSzVyPUSwMlgzKG6P	NF3nPWxUSU6JRWK=
HT	NHnaTlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUfRfmxLUUN3ME20NU4xOiCwTR?=	NG\neW1USU6JRWK=
8305C	Mk[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mo\FTWM2OD12MT64O{BvVQ>?	MoD1V2FPT0WU
BHY	M{jBS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4flbmlEPTB;NEKuO\|Ihdk1?	M1zxcXNCVkeHUh?=
NTERA-S-cl-D1	NFHv[5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXXZNppQUUN3ME20N{BvVQ>?	Mn\JV2FPT0WU
T-24	NFXuR2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYnJR\|UxRTR\|LkizJI5O	M3\uXnNCVkeHUh?=
EPLC-272H	NUC2OmhZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWDWOY9JUUN3ME20OE4{QSCwTR?=	Mkn0V2FPT0WU
PSN1	NF7QfWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFz4bFRKSzVyPUS0MlQhdk1?	MmPDV2FPT0WU
NCI-H2452	M{HQbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NY\XclMyUUN3ME20OE42QCCwTR?=	NUDMZo1LW0GQR1XS
KS-1	Mof3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGOwRphKSzVyPUS0MlY3KG6P	M{\2N3NCVkeHUh?=
HD-MY-Z	MmHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWO4fXNSUUN3ME20OE46OiCwTR?=	MWPTRW5ITVJ?
KNS-62	NYf0WlVsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlvPTWM2OD12NT6zPEBvVQ>?	NVTE[WY5W0GQR1XS
NOMO-1	MmnUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHTjeoZKSzVyPUS1Mlg4KG6P	NVHZWpNMW0GQR1XS
SK-HEP-1	NYXtRXFMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{SwXWlEPTB;NE[uNFQhdk1?	NIm1SFZUSU6JRWK=
IGR-1	NELX[JlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoLKTWM2OD12Nj6xN{BvVQ>?	NU\5Z4ZKW0GQR1XS
KYSE-180	MlflS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3fTVmlEPTB;NE[uNVchdk1?	MUfTRW5ITVJ?
EW-22	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVzFUmZ7UUN3ME20Ok4zKG6P	Mki4V2FPT0WU
NCI-H1355	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGLEZYJKSzVyPUS2MlM1KG6P	M{fmR3NCVkeHUh?=
DOHH-2	MnyyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M17zcWlEPTB;NE[uN\|chdk1?	M4rYdnNCVkeHUh?=
A4-Fuk	NXHGcXdFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVTjRVBQUUN3ME20Ok42OiCwTR?=	NGT2PHlUSU6JRWK=
PC-14	NH3zelRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWfJR\|UxRTR4LkW3JI5O	M{S0dXNCVkeHUh?=
TE-5	Mn\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\xN4dKSzVyPUS2Mlg1KG6P	MkXZV2FPT0WU
LB996-RCC	NVzBdGtQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3Lq[WlEPTB;NEeuNVkhdk1?	NUjZNoVpW0GQR1XS
NCI-H1623	MlnhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF7Ib3pKSzVyPUS3Mlc3KG6P	M3LmW3NCVkeHUh?=
NCI-H1155	NYXqb5dmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFjD[YlKSzVyPUS4MlMzKG6P	NHfPcndUSU6JRWK=
LoVo	NHi4[GhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnXZTWM2OD12OD60JI5O	M{DsdXNCVkeHUh?=
MCF7	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MU\JR\|UxRTR6LkW4JI5O	NUfDTpo{W0GQR1XS
AGS	MojFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV7JR\|UxRTR6Lke3JI5O	M1HOdXNCVkeHUh?=
PFSK-1	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlXtTWM2OD12OT6wOkBvVQ>?	M37renNCVkeHUh?=
22RV1	NWi3TIl{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHW0WmRKSzVyPUS5MlA6KG6P	MUnTRW5ITVJ?
COR-L23	NWq3OZdJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmLzTWM2OD12OT6xOkBvVQ>?	NFSzRllUSU6JRWK=
D-283MED	M1;nNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXj4ZlBkUUN3ME20PU43OSCwTR?=	NGm2fFlUSU6JRWK=
SW982	NULmOYw6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYHJR\|UxRTR7LkmxJI5O	MXvTRW5ITVJ?
SW620	NEfad\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mo\6TWM2OD13MD6zOkBvVQ>?	MlfBV2FPT0WU
KYSE-140	M1zsUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYnJR\|UxRTVyLkW1JI5O	NXW4OHB1W0GQR1XS
GCIY	M1fFcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIjxXYNKSzVyPUWwMlY4KG6P	MoX0V2FPT0WU
MHH-ESS-1	M4DJRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWLRNZRJUUN3ME21NU46PSCwTR?=	M{HWWXNCVkeHUh?=
D-423MG	M1\4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1K2RWlEPTB;NUKuNFghdk1?	MlnhV2FPT0WU
SF539	NW[1b\|RrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1z0SGlEPTB;NUKuN\|Uhdk1?	MnvPV2FPT0WU
RPMI-2650	M3;JWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWjJR\|UxRTV{Lk[5JI5O	NU\hZoVTW0GQR1XS
GR-ST	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{nYZ2lEPTB;NUKuPFchdk1?	NYHHTVJRW0GQR1XS
YKG-1	MnfSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWjVdGpoUUN3ME21N{BvVQ>?	NFTuTJlUSU6JRWK=
SK-MES-1	M3XuUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnzETWM2OD13Mz6yOkBvVQ>?	M{jYcXNCVkeHUh?=
HLE	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NE\sclhKSzVyPUWzMlQ4KG6P	NETObVdUSU6JRWK=
RVH-421	M3OwbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmjCTWM2OD13Mz62O{BvVQ>?	MVLTRW5ITVJ?
C32	NX74fYtYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFG1c\|ZKSzVyPUWzMlg{KG6P	NIDI[YVUSU6JRWK=
GB-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2[2NWlEPTB;NUSuNkBvVQ>?	NUG1VlR[W0GQR1XS
SNB75	NHP2b2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1ribWlEPTB;NUSuNlYhdk1?	NF\yZ4JUSU6JRWK=
EM-2	NGXFNXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mof5TWM2OD13ND60JI5O	NHLWfXFUSU6JRWK=
RH-1	M37IfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWDJPFVPUUN3ME21OE44KG6P	NX35ZnplW0GQR1XS
NKM-1	M3O5[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{jQWmlEPTB;NUSuPFEhdk1?	MX\TRW5ITVJ?
NCI-H2405	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXP2S5pmUUN3ME21OE45QCCwTR?=	NYHOTVdCW0GQR1XS
KYSE-450	NG\BNVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVTITIpIUUN3ME21OU4yPiCwTR?=	NE\EXJpUSU6JRWK=
A704	NVTvN2tTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIDQT3pKSzVyPUW1MlU6KG6P	NUnB[2lqW0GQR1XS
HAL-01	M3jpS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXnJR\|UxRTV3LkizJI5O	NIjTT2lUSU6JRWK=
TE-11	M4nE[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn\PTWM2OD13NT65PUBvVQ>?	M1POZXNCVkeHUh?=
DOK	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnTITWM2OD13Nj6wNkBvVQ>?	M{jFN3NCVkeHUh?=
KY821	MmPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2qyNmlEPTB;NU[uNkBvVQ>?	NVjjNWdvW0GQR1XS
KGN	Mn3PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFPTb5VKSzVyPUW2MlMzKG6P	M4rkSnNCVkeHUh?=
MC116	M4fBNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4DtSGlEPTB;NUeuPEBvVQ>?	M2npbnNCVkeHUh?=
PANC-08-13	MoKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGXmPGFKSzVyPUW4MlAyKG6P	MVnTRW5ITVJ?
KE-37	NF\Kd\|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkXXTWM2OD13OD63O{BvVQ>?	M3;WO3NCVkeHUh?=
KYSE-410	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4fEb2lEPTB;NUmuOFchdk1?	Ml3RV2FPT0WU
RO82-W-1	NVHHNZRuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGOwO3pKSzVyPUW5Mlkhdk1?	NVL3NFhSW0GQR1XS
M14	MlqzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV3SPYhKUUN3ME22NE4xPCCwTR?=	Mkm2V2FPT0WU
GI-1	MnXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIrsV4tKSzVyPU[wMlMhdk1?	NWHVc5VCW0GQR1XS
ML-2	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmjOTWM2OD14MD62NkBvVQ>?	MoXVV2FPT0WU
BFTC-905	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGji[lRKSzVyPU[wMlY2KG6P	NW[0VWZiW0GQR1XS
DMS-273	NE\ucHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWHJR\|UxRTZyLki3JI5O	MYPTRW5ITVJ?
MDA-MB-361	Ml3NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGLlTJhKSzVyPU[xJI5O	NUPPS3ZWW0GQR1XS
MSTO-211H	NI\PfGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVjJR\|UxRTZ\|LkWxJI5O	MX\TRW5ITVJ?
MEG-01	MmjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGPVVIFKSzVyPU[zMlUzKG6P	M3TqPHNCVkeHUh?=
M059J	Mny1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NW\lcIJiUUN3ME22N{42QCCwTR?=	MVvTRW5ITVJ?
LN-405	M2fDTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1X1PGlEPTB;NkOuPFUhdk1?	MmLwV2FPT0WU
NCI-H1581	M3LiUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4KwTGlEPTB;NkSuNFMhdk1?	M1nWSHNCVkeHUh?=
TCCSUP	NFvUZVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXnJR\|UxRTZ2LkWzJI5O	NYjN[ZhiW0GQR1XS
SW872	M{fIRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFu4W3dKSzVyPU[0MlU4KG6P	NUi2bHNQW0GQR1XS
KYSE-510	M3TzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXvJR\|UxRTZ3Lke1JI5O	NHvOSopUSU6JRWK=
NCI-H1792	MknjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYnJR\|UxRTZ4LkG1JI5O	NHjhZnhUSU6JRWK=
SW13	NV\UfpROT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3vjO2lEPTB;Nk[uOUBvVQ>?	NIjm[2JUSU6JRWK=
TE-8	MkC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGDVbZdKSzVyPU[2MlUzKG6P	MULTRW5ITVJ?
SCH	MmfzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYDJR\|UxRTZ5LkGgcm0>	NHr2XYVUSU6JRWK=
NEC8	MlTMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoDlTWM2OD14Nz6yOEBvVQ>?	NEnQPGJUSU6JRWK=
HuO-3N1	NGjjO5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXX6OIxQUUN3ME22O{4{OSCwTR?=	MWrTRW5ITVJ?
EFM-19	NH7UPWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUn1TlRrUUN3ME22O{42KG6P	M2Hj[nNCVkeHUh?=
HEC-1	NXjuT2o5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGG1d2ZKSzVyPU[3MlUzKG6P	MUjTRW5ITVJ?
T47D	NV3QSZQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFXuV3lKSzVyPU[3Mlg4KG6P	NFfxe\|dUSU6JRWK=
SNU-423	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnLjTWM2OD14Nz65PEBvVQ>?	M4L0cHNCVkeHUh?=
WM-115	NW\iSJVNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkLjTWM2OD14OD6xOEBvVQ>?	M4G0[nNCVkeHUh?=
CaR-1	MnGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M33PcWlEPTB;NkiuNlUhdk1?	NE\rXItUSU6JRWK=
KU812	NUDySI9sT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4HMbGlEPTB;NkiuOlkhdk1?	MX7TRW5ITVJ?
AM-38	M16wNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3THOWlEPTB;NkmuN\|Ehdk1?	NVnGNVFnW0GQR1XS
KOSC-2	NF:3VXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHjLSJRKSzVyPU[5Mlk4KG6P	MnTvV2FPT0WU
MC-IXC	NXrw[5FbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{PXbmlEPTB;N{CuNFghdk1?	MXzTRW5ITVJ?
SCC-4	MkOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXmy[VJmUUN3ME23NU4{QCCwTR?=	MX3TRW5ITVJ?
Calu-3	MkDTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV\iVGh3UUN3ME23NU46QCCwTR?=	MnTmV2FPT0WU
RPMI-8866	NVPsUJFoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M37QN2lEPTB;N{KuPFIhdk1?	MYXTRW5ITVJ?
OVCAR-4	M3TFfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mo[4TWM2OD15Mz6zOkBvVQ>?	NYLKZpZjW0GQR1XS
OAW-42	NX\WNmVRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXjJR\|UxRTd\|LkO5JI5O	MXLTRW5ITVJ?
ATN-1	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NV3Te29OUUN3ME23N{45PyCwTR?=	MYHTRW5ITVJ?
CHP-212	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NW\5PI1QUUN3ME23OE46PSCwTR?=	NIjIfVNUSU6JRWK=
C2BBe1	M37RfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn7LTWM2OD15NT6wN{BvVQ>?	NHvUOHBUSU6JRWK=
A498	M1;Ie2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGGydFNKSzVyPUe1MlE2KG6P	NXjXZ4dXW0GQR1XS
SH-4	NIPENVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXnJR\|UxRTd3LkKxJI5O	MXvTRW5ITVJ?
SNU-449	NU\LOHhDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M131OWlEPTB;N{WuO\|khdk1?	MkjaV2FPT0WU
RD	NX2wRWtHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NITBdWlKSzVyPUe1Mlg3KG6P	M37Cc3NCVkeHUh?=
PANC-03-27	NY\0S4NoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVrJR\|UxRTd4LkK1JI5O	Mmr3V2FPT0WU
S-117	M1LMSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2O1VWlEPTB;N{[uNlchdk1?	NUPrWHVrW0GQR1XS
SK-MEL-2	M3HFd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXzJR\|UxRTd4Lke1JI5O	Mn70V2FPT0WU
LK-2	MlvnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYDJR\|UxRTd5LkC1JI5O	M4DMcXNCVkeHUh?=
CP50-MEL-B	NEOz[YhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M33aPGlEPTB;N{euOEBvVQ>?	MVLTRW5ITVJ?
647-V	NGm1dldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWPJR\|UxRTd6LkC3JI5O	MUfTRW5ITVJ?
LU-134-A	NFrXVWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mo\xTWM2OD15OT6wN{BvVQ>?	MlP4V2FPT0WU
5637	NH7UbpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV;me4tqUUN3ME23PU4zOyCwTR?=	M1\KVHNCVkeHUh?=
NCI-H1437	NVrmbYRLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3Xw[mlEPTB;OECuOUBvVQ>?	NIDVV2JUSU6JRWK=
NCI-H460	NHnWNIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWrJR\|UxRThzLkKzJI5O	M4TjNnNCVkeHUh?=
BxPC-3	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEHPTFhKSzVyPUixMlQ3KG6P	MkTpV2FPT0WU
CAN	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHPQ[llKSzVyPUixMlg1KG6P	MofsV2FPT0WU
KINGS-1	NYn4cZF4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M37hW2lEPTB;OEKuN\|Ihdk1?	MXrTRW5ITVJ?
OCUB-M	M3rCbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MW\JR\|UxRTh{LkSxJI5O	M2\wU3NCVkeHUh?=
KALS-1	NYXMc\|ZoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3vObWlEPTB;OEKuOVQhdk1?	NUXUenQ1W0GQR1XS
OCI-AML2	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3v0RWlEPTB;OEKuOlEhdk1?	M4rC[XNCVkeHUh?=
A253	NFXXTm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlHXTWM2OD16Mj62OUBvVQ>?	MVfTRW5ITVJ?
LCLC-97TM1	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{nmdGlEPTB;OEKuPFYhdk1?	NHTvVmxUSU6JRWK=
NCI-H520	NHXQW\|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFv1Z2FKSzVyPUizMlA3KG6P	NXG2b2lkW0GQR1XS
P30-OHK	NH\zOnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MU\JR\|UxRTh\|LkWgcm0>	MoLzV2FPT0WU
SBC-5	NHHCNlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXnJR\|UxRTh\|LkWyJI5O	M1ThNnNCVkeHUh?=
HCE-T	NHH5bZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVi3UXo6UUN3ME24N{44PCCwTR?=	NEPucWdUSU6JRWK=
JEG-3	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkDOTWM2OD16ND6xJI5O	NYO0em9SW0GQR1XS
KG-1	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHrhdHlKSzVyPUi0MlI1KG6P	NX25TFcxW0GQR1XS
MIA-PaCa-2	M4\KSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV33fHdUUUN3ME24OE42PCCwTR?=	M1rUW3NCVkeHUh?=
CAL-33	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3fLeWlEPTB;OEWuNFghdk1?	NWfkeY9DW0GQR1XS
639-V	MoG2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWrJR\|UxRTh3LkSyJI5O	NXuxUHJJW0GQR1XS
NCI-H1048	NH\UfJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYjJR\|UxRTh4LkOxJI5O	NUjSeIhnW0GQR1XS
NCI-H1573	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3HIeWlEPTB;OEeuOFghdk1?	NEDK[YVUSU6JRWK=
NCI-H2228	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWHBcYVwUUN3ME24PE4zPiCwTR?=	MVfTRW5ITVJ?
NB14	M2jHeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEDUV5RKSzVyPUi4MlMhdk1?	NV[4bpdFW0GQR1XS
SCC-25	M2W1T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2DpUmlEPTB;OEmuPFIhdk1?	Mnj5V2FPT0WU
A431	NYLNepN4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFy0c5VKSzVyPUi5Mlk4KG6P	NFSzTnRUSU6JRWK=
SN12C	Mk\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHHOZXBKSzVyPUmwMlYzKG6P	MnXxV2FPT0WU
HuCCT1	NWL6VGhGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGLid3RKSzVyPUmwMlc3KG6P	MWLTRW5ITVJ?
LS-123	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NU\TfZJXUUN3ME25Nk4yQCCwTR?=	MnGzV2FPT0WU
CAL-85-1	NGGyZoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWjPVY86UUN3ME25Nk41QCCwTR?=	NWPuWlB5W0GQR1XS
ES6	NWCxdodpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV7oV25QUUN3ME25Nk45OyCwTR?=	NG\3VVlUSU6JRWK=
NCI-H650	NY[5T2Z[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYnvZ3pmUUN3ME25OE4xQSCwTR?=	MX\TRW5ITVJ?
NCI-H446	MkLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXLXSIs{UUN3ME25OU4yOiCwTR?=	M3rFUnNCVkeHUh?=
EW-13	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWfOXYY1UUN3ME25OU44PSCwTR?=	MXXTRW5ITVJ?
HSC-2	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NELWSYFKSzVyPUm1Mlg6KG6P	NEDZfpZUSU6JRWK=
U031	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXLBepdMUUN3ME25Ok44OyCwTR?=	M1nPZnNCVkeHUh?=
EW-11	NHLVbmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWrHWIRtUUN3ME25Ok45QCCwTR?=	MonoV2FPT0WU
GAK	NITmTGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3TkXGlEPTB;OUiuPVMhdk1?	M4HRZ3NCVkeHUh?=
SK-OV-3	NIXRb\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlvSTWM2OD1zMECuNFchdk1?	MXPTRW5ITVJ?
OMC-1	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHnwb3pKSzVyPUGwNE4yQCCwTR?=	NIHwbYxUSU6JRWK=
TK10	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHjLOYJKSzVyPUGwNE4zOSCwTR?=	MnjMV2FPT0WU
EKVX	NGHXcGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV7VZZJVUUN3ME2xNFAvPiCwTR?=	NFzPPJFUSU6JRWK=
Detroit562	NFzKeVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGSxNVBKSzVyPUGwNk4yPyCwTR?=	M1zJTXNCVkeHUh?=
SF268	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYmy[3ZuUUN3ME2xNFIvOzRibl2=	MYXTRW5ITVJ?
SNU-387	NVrsUnVWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Moj2TWM2OD1zMESuNVchdk1?	NHzzUZFUSU6JRWK=
MDA-MB-231	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXzJR\|UxRTFyNT6wOkBvVQ>?	MmPhV2FPT0WU
NCI-H1563	NIjBOYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYmzS4o2UUN3ME2xNFUvOThibl2=	MoW0V2FPT0WU
D-502MG	MljyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoHsTWM2OD1zMEWuO{BvVQ>?	NXSxNVI1W0GQR1XS
A2780	NIPVOXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlXJTWM2OD1zME[uOFchdk1?	NVXvXnNNW0GQR1XS
IA-LM	NH\DWFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWHsepVFUUN3ME2xNFcvPTFibl2=	MVvTRW5ITVJ?
D-392MG	NH7MRYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWGzNpc4UUN3ME2xNFcvPTRibl2=	NVHzbZY4W0GQR1XS
MS-1	M{C1OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFnmdlhKSzVyPUGwO{44OSCwTR?=	M3nvdXNCVkeHUh?=
SW1990	M4fZWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIX5UGRKSzVyPUGwPE42PCCwTR?=	MmrXV2FPT0WU
HEL	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmK2TWM2OD1zMEmuNlkhdk1?	NHnHbpNUSU6JRWK=
SW1573	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NG\Zb\|lKSzVyPUGwPU4{OSCwTR?=	MYXTRW5ITVJ?
SW1783	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYnJR\|UxRTFzMD6yNkBvVQ>?	MlLaV2FPT0WU
COLO-680N	M13sd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXjrflNmUUN3ME2xNVAvPzZibl2=	NFvxdW1USU6JRWK=
NCI-N87	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmnTTWM2OD1zMUGuNFQhdk1?	NV62TGdqW0GQR1XS
SK-MEL-28	Mo\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGXGTYFKSzVyPUGxNU42PSCwTR?=	MVLTRW5ITVJ?
BT-20	NX\xeWJtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIrWOmRKSzVyPUGxNk4xOSCwTR?=	NYK2VIFQW0GQR1XS
NCI-H1648	M1GwR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWDWXIpEUUN3ME2xNVMhdk1?	M4PyUnNCVkeHUh?=
no-11	MmSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoDBTWM2OD1zMUOuNlghdk1?	M1TGdnNCVkeHUh?=
MOLT-13	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEnpW21KSzVyPUGxN{41PCCwTR?=	MVPTRW5ITVJ?
NCI-H2170	NHfFU4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkL4TWM2OD1zMUSuOVEhdk1?	MmKyV2FPT0WU
HTC-C3	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mof1TWM2OD1zMU[uPFUhdk1?	MWfTRW5ITVJ?
LU-99A	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWnJR\|UxRTFzNz6yNUBvVQ>?	NIPOcYZUSU6JRWK=
HCC2998	NVrVZlg3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVPJR\|UxRTFzNz65NkBvVQ>?	M2LXSnNCVkeHUh?=
NB13	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1PvVGlEPTB;MUG3Mlk6KG6P	Mk[zV2FPT0WU
GT3TKB	NFP5VJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVHJR\|UxRTFzOD6wPEBvVQ>?	NEHweFBUSU6JRWK=
BT-549	NFf2[mFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVHoU4FNUUN3ME2xNVgvQTVibl2=	NE\VPYxUSU6JRWK=
NCI-H747	MoTTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH;1b\|FKSzVyPUGxPU4{PCCwTR?=	M1fP[XNCVkeHUh?=
EW-1	MljZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MknxTWM2OD1zMkCuNkBvVQ>?	NXezRmV5W0GQR1XS
LB831-BLC	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4\EbmlEPTB;MUKwMlY{KG6P	NYjzWWY1W0GQR1XS
NMC-G1	M33vZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHHxdIVKSzVyPUGyNU4yOSCwTR?=	M2rPbXNCVkeHUh?=
COLO-679	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnHUTWM2OD1zMkKuNVUhdk1?	MkOxV2FPT0WU
HL-60	NEi1TWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWnJR\|UxRTF{Mz6xJI5O	NFj4e4FUSU6JRWK=
MKN7	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MojDTWM2OD1zMkOuPFMhdk1?	NFzwc3pUSU6JRWK=
RERF-LC-MS	Mo\CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3nvfGlEPTB;MUK0MlMyKG6P	MnLkV2FPT0WU
DMS-114	NHT1XVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXfJR\|UxRTF{NT6wPUBvVQ>?	NYfIZXA2W0GQR1XS
HuP-T4	MmHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmTMTWM2OD1zMk[uPVchdk1?	M2n0fXNCVkeHUh?=
HCC2157	NUT3SppJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MV\JR\|UxRTF{Nz61JI5O	MV\TRW5ITVJ?
SKG-IIIa	M4[zN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{K2NWlEPTB;MUK4Mlghdk1?	NID0O4VUSU6JRWK=
HCT-116	M3PzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGfveGdKSzVyPUGzNE43PCCwTR?=	NY\w[npiW0GQR1XS
BB30-HNC	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnzqTWM2OD1zM{CuO\|ghdk1?	NUTxTGpRW0GQR1XS
KYSE-270	NGLPPWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHr0fmtKSzVyPUGzNE45QCCwTR?=	NH;JRXNUSU6JRWK=
MFM-223	NWjQPYlWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXvtR3IzUUN3ME2xN\|EvPTFibl2=	MX3TRW5ITVJ?
NH-12	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH;wO5RKSzVyPUGzNk46QSCwTR?=	MlnpV2FPT0WU
U-118-MG	NVf0[FUxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVzuenRbUUN3ME2xN\|MvPjJibl2=	NVn1ZoZSW0GQR1XS
ESS-1	M3PiV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NELwV4dKSzVyPUGzOU4yQCCwTR?=	M4TBRXNCVkeHUh?=
D-247MG	M2LzcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2j6bWlEPTB;MUO1MlIyKG6P	NES5U49USU6JRWK=
IGROV-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnuwTWM2OD1zM{WuO\|Yhdk1?	Ml\xV2FPT0WU
C-33-A	NXTFemFsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYHpS3VDUUN3ME2xN\|UvQTdibl2=	M4iyNXNCVkeHUh?=
NCI-H1693	MlPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkDWTWM2OD1zM{[uNVIhdk1?	MlPrV2FPT0WU
MLMA	Ml\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV;SR5pxUUN3ME2xN\|YvPThibl2=	MWXTRW5ITVJ?
SK-N-AS	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGjLTo9KSzVyPUGzO{4yPyCwTR?=	MmraV2FPT0WU
NCI-H1755	MnHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUPJR\|UxRTF\|OD64OUBvVQ>?	MYLTRW5ITVJ?
CHP-134	NELYVo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWrReVI1UUN3ME2xN\|kvPTVibl2=	Ml[yV2FPT0WU
LS-513	NEmy[m5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2XGOmlEPTB;MUSwMlkyKHCP	NHX0WJVUSU6JRWK=
TE-12	MlLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYnpbVRlUUN3ME2xOFAvQTNibl2=	NFfYV2pUSU6JRWK=
KNS-42	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXHwdHFWUUN3ME2xOFQvOyCwTR?=	NELsb3NUSU6JRWK=
SJRH30	NUW0UGp1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{X4TWlEPTB;MUS0MlQ1KG6P	MlrqV2FPT0WU
NCI-H1092	MlfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml7LTWM2OD1zNESuOVIhdk1?	Mlf6V2FPT0WU
H-EMC-SS	MkLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEjVTWNKSzVyPUG0Ok45OSCwTR?=	M4m3VnNCVkeHUh?=
SK-MEL-3	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXvJR\|UxRTF2Nz61OUBvVQ>?	NWrydW92W0GQR1XS
SK-N-FI	NH[5Vo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4jOZWlEPTB;MUS3MlU6KG6P	MUDTRW5ITVJ?
NCI-H2126	NFvEZlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4\rZWlEPTB;MUS4MlE2KG6P	NXHCSWRPW0GQR1XS
NCI-H1299	NX;E[HVwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3ryeGlEPTB;MUWwMlIzKG6P	NG\rc3JUSU6JRWK=
CFPAC-1	NV61Rol4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1L3Z2lEPTB;MUWwMlY3KG6P	MULTRW5ITVJ?
NCI-H661	NF7SeHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlXYTWM2OD1zNUGuNlYhdk1?	NHHvfoZUSU6JRWK=
KYSE-70	NVv0NGg4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3LRU2lEPTB;MUWxMlc6KG6P	MV;TRW5ITVJ?
SW900	NVXJ[XRzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NW\LWVdtUUN3ME2xOVQvPjVibl2=	MlzvV2FPT0WU
Ca-Ski	M37ITmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4X0SWlEPTB;MUW2MlM6KG6P	MXTTRW5ITVJ?
HPAF-II	M2nscWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYDJR\|UxRTF3Nj60O{BvVQ>?	NIS1UnhUSU6JRWK=
LB2518-MEL	NWHxU3FkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYDJR\|UxRTF3Nz6xJI5O	MoriV2FPT0WU
LC-2-ad	M1\TcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmPxTWM2OD1zNUiuOlIhdk1?	M134fXNCVkeHUh?=
HCC1806	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFqxUGRKSzVyPUG2O{45QCCwTR?=	Mlq4V2FPT0WU
UACC-62	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF7TZ3FKSzVyPUG2PE4xQSCwTR?=	MljiV2FPT0WU
KM-H2	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWXSVXlRUUN3ME2xO\|AvPThibl2=	M13pOHNCVkeHUh?=
NCI-H2347	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGPa[GxKSzVyPUG3Nk44OiCwTR?=	Mni1V2FPT0WU
SCC-15	NEL4dWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnP0TWM2OD1zN{OuOlYhdk1?	MkHRV2FPT0WU
BB49-HNC	NV;oW\|EyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF72R5lKSzVyPUG3N{45OSCwTR?=	NW[2TFZDW0GQR1XS
GMS-10	MlLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUDrbnRiUUN3ME2xO\|MvQTRibl2=	MoPjV2FPT0WU
NCI-H2052	NGP3fXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXnKSWg6UUN3ME2xO\|QvQSCwTR?=	M{nMRXNCVkeHUh?=
SW626	NXH6dFJTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFWzeGRKSzVyPUG3Ok4xPiCwTR?=	MXnTRW5ITVJ?
MDA-MB-415	NXvoSJhwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1G4c2lEPTB;MUe2MlYyKG6P	MUnTRW5ITVJ?
Saos-2	NEPZSY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkLMTWM2OD1zN{muN\|Uhdk1?	NWfpPI5qW0GQR1XS
DK-MG	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIHJRXZKSzVyPUG4NE4{KG6P	MnjZV2FPT0WU
SNU-C2B	Mn3SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmPWTWM2OD1zOECuO\|Mhdk1?	Mm\wV2FPT0WU
A427	M4fvVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUHJR\|UxRTF6Mj61O{BvVQ>?	MoDxV2FPT0WU
KP-N-YS	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4jiN2lEPTB;MUi1JI5O	MnfDV2FPT0WU
J82	MmLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWDBTWZ2UUN3ME2xPFUvOThibl2=	MUXTRW5ITVJ?
LS-411N	Mm\RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVrJR\|UxRTF6Nz6yPEBvVQ>?	MnqxV2FPT0WU
HCC1937	MofxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWLpOm9YUUN3ME2xPFcvPDlibl2=	MWPTRW5ITVJ?
OE33	MnvCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX3JR\|UxRTF6OD65O{BvVQ>?	NFq5U2pUSU6JRWK=
NB7	M{C4fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{H1ZWlEPTB;MUi5Mlg6KG6P	M{GyWXNCVkeHUh?=
SW684	NI[4c4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEHxfYxKSzVyPUG5Ok4yOyCwTR?=	M{jrPXNCVkeHUh?=
HT-144	MlLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1fE[WlEPTB;MUm2MlE2KG6P	M1TTPHNCVkeHUh?=
SK-MEL-30	M2\jeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnfDTWM2OD1zOU[uNkBvVQ>?	NGH3UXBUSU6JRWK=
DBTRG-05MG	NHfOOmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXnJR\|UxRTF7OD60O{BvVQ>?	NUn1NpNjW0GQR1XS
NCI-H1395	MkGyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3vqWmlEPTB;MUm4Mlg2KG6P	MlzaV2FPT0WU
NCI-H2122	NFfuOo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYH0Wnd7UUN3ME2yNFAvPTlibl2=	MXnTRW5ITVJ?
no-10	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2PLVWlEPTB;MkCxMlA1KG6P	NHTxUlFUSU6JRWK=
SW48	NET5U4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXvJR\|UxRTJyMT6zNUBvVQ>?	M{LUSHNCVkeHUh?=
NCI-H1650	NYH1T\|BjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUmyeFJpUUN3ME2yNFQvODFibl2=	NVTQUFNwW0GQR1XS
MZ1-PC	MmjrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGGyTW5KSzVyPUKwOU42QCCwTR?=	M4rMbXNCVkeHUh?=
U-266	M3rzS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVXMdGZPUUN3ME2yNFUvPzlibl2=	NYnhPXJGW0GQR1XS
CAS-1	NGHlOnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MonPTWM2OD1{MEeuOFQhdk1?	NE\Cc21USU6JRWK=
AU565	M4i0S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXH0T5YxUUN3ME2yNVIvQDJibl2=	NX7EU3lRW0GQR1XS
UACC-257	NWCwN\|NvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXTK[IZ7UUN3ME2yNVMvQTlibl2=	M1L2NnNCVkeHUh?=
CAL-27	NWjke3ZkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXLJR\|UxRTJzNz6wOUBvVQ>?	M2j1U3NCVkeHUh?=
NCI-H23	MkSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUDJR\|UxRTJzOT6zN{BvVQ>?	NHTrOpdUSU6JRWK=
TE-6	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGnvZY9KSzVyPUKxPU43QCCwTR?=	NVriWHB1W0GQR1XS
TGBC24TKB	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3;BZmlEPTB;MkKyMlE4KG6P	M2fje3NCVkeHUh?=
TE-1	MnHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV3JR\|UxRTJ{Mj64PEBvVQ>?	NF3jSIxUSU6JRWK=
RCC10RGB	NIPNWG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{DPZWlEPTB;MkK0MlE6KG6P	NV63ZlhCW0GQR1XS
NCI-H596	NWXTTXliT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFXRNVNKSzVyPUKyPE4zOiCwTR?=	MkHXV2FPT0WU
SW954	M3O3O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{jHXGlEPTB;MkOzMlg{KG6P	NWHCWpdrW0GQR1XS
NCI-H2087	MmXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2fGTmlEPTB;MkO0MlUyKG6P	M2mzTnNCVkeHUh?=
SK-PN-DW	NHixV49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MomxTWM2OD1{M{WuNVkhdk1?	NXG3NZlsW0GQR1XS
KM12	NID0WldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3rQS2lEPTB;MkO1Mlchdk1?	M{XoZ3NCVkeHUh?=
BT-474	NWTG[I96T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX[yT3dMUUN3ME2yN\|UvPzNibl2=	M2fIbnNCVkeHUh?=
IST-MES1	NIjGfGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWW0fmhPUUN3ME2yN\|YvPTdibl2=	NUHxcHFMW0GQR1XS
HT-1197	NHXvfHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NX3rbWZRUUN3ME2yN\|gvODlibl2=	NEfXWVhUSU6JRWK=
CAL-54	MkjaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUDJR\|UxRTJ\|OD60PUBvVQ>?	M1TGdnNCVkeHUh?=
NB10	NF71[lJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGjH[3dKSzVyPUK0NE4xPiCwTR?=	MYXTRW5ITVJ?
PANC-10-05	NXjmfZBJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYPtWIhsUUN3ME2yOFUvPTZibl2=	NHPsRXJUSU6JRWK=
NCI-H522	M4TPcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXjaenl3UUN3ME2yOFgvOzFibl2=	NEDGNZlUSU6JRWK=
A388	NFGzW2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlPJTWM2OD1{NEmuPFIhdk1?	MkfQV2FPT0WU
GOTO	NVLs[YtuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF\QfJZKSzVyPUK1NE4zQSCwTR?=	NHnOd3ZUSU6JRWK=
KLE	NX\JPIJRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX3Oe3lJUUN3ME2yOVEvQDdibl2=	NHzOWYxUSU6JRWK=
KYSE-520	NGXqSodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVTJR\|UxRTJ3Mj64OkBvVQ>?	MWjTRW5ITVJ?
HCE-4	NHfRdJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MY\JR\|UxRTJ4Mj61JI5O	NHuzU2RUSU6JRWK=
KURAMOCHI	M3;rVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2fFNWlEPTB;Mk[1Mlkhdk1?	M13GZ3NCVkeHUh?=
HCC38	MmqzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFXHR2hKSzVyPUK2Ok41QCCwTR?=	NGCyWItUSU6JRWK=
FADU	NUi0bXhYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXLJR\|UxRTJ4Nj62N{BvVQ>?	M3LLO3NCVkeHUh?=
CW-2	NGjvT2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV7JR\|UxRTJ4OT65OkBvVQ>?	NVy1UVF3W0GQR1XS
L-428	M4r3Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4j1TmlEPTB;Mke1MlE2KG6P	MlTjV2FPT0WU
HCC1569	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXuwUlJrUUN3ME2yO\|UvQDRibl2=	Mnr0V2FPT0WU
NCI-H810	NXzjPYNxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUPCXYt5UUN3ME2yO\|gvOzFibl2=	NVXBTFc4W0GQR1XS
LB771-HNC	Mn\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIjDfGhKSzVyPUK4OU45PCCwTR?=	MXTTRW5ITVJ?
LCLC-103H	MoXlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmnOTWM2OD1{OEWuPVkhdk1?	MUDTRW5ITVJ?
EFO-21	M364Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH:0W5BKSzVyPUK4O{43QCCwTR?=	NIXiNYlUSU6JRWK=
CAL-72	M{\3UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUXJR\|UxRTJ7Mz6xPUBvVQ>?	MWrTRW5ITVJ?
SCC-9	MnroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYTJR\|UxRTJ7Mz6yNkBvVQ>?	NFPLNlJUSU6JRWK=
COLO-829	M4nPfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEXxZlFKSzVyPUK5Ok42KG6P	MXjTRW5ITVJ?
U-87-MG	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX;JR\|UxRTNyMD63N{BvVQ>?	M1rxbnNCVkeHUh?=
MZ7-mel	NYjNZ2tPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVjhbZRHUUN3ME2zNlMvPzZibl2=	Ml\iV2FPT0WU
NCI-H1770	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFTnV4tKSzVyPUOyOk44PCCwTR?=	MmC4V2FPT0WU
ChaGo-K-1	MoXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV\JR\|UxRTN{OD6xJI5O	M2TydHNCVkeHUh?=
SiHa	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX;JR\|UxRTN{OT6yOEBvVQ>?	NI[xbFFUSU6JRWK=
NCI-SNU-5	MnS5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH3FSXJKSzVyPUOzOk44PyCwTR?=	NXvwUlVQW0GQR1XS
DJM-1	NH\5XVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFvReHhKSzVyPUO0NE4{OyCwTR?=	Mn7OV2FPT0WU
OE19	M3PXdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFHnfVVKSzVyPUO0NE42OyCwTR?=	M4L6[HNCVkeHUh?=
NCI-H1651	Mlz2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M17iTmlEPTB;M{S0MlE5KG6P	NF\rU\|NUSU6JRWK=
COLO-792	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWfJR\|UxRTN3ND60NkBvVQ>?	NV\JZVNXW0GQR1XS
ACHN	M4\s[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M33qZmlEPTB;M{W2MlcyKG6P	NXLvZnM3W0GQR1XS
TH-3	NX3md2pkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYPJR\|UxRTN5OT65OUBvVQ>?	M1\3NnNCVkeHUh?=
HT-1376	MnfVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHPWXZJKSzVyPUO4OE45QCCwTR?=	M1fYWnNCVkeHUh?=
RH-18	M3TkU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUjhNJdVUUN3ME2zPVQvPzRibl2=	M2HkNHNCVkeHUh?=
NB6	NEDPcIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4K1[2lEPTB;M{m2MlY3KG6P	MoK3V2FPT0WU
COLO-320-HSR	NVXaXJVLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXnJR\|UxRTRyMz6zO{BvVQ>?	NIjpZ5NUSU6JRWK=
UACC-893	M{\OV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkPyTWM2OD12ME[uOFchdk1?	NW[zd3FMW0GQR1XS
DSH1	M2jGemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGDRPYVKSzVyPUSwOk46OSCwTR?=	MVHTRW5ITVJ?
TE-10	NHi0UXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVzJR\|UxRTRyNz6wNUBvVQ>?	MUTTRW5ITVJ?
HCC70	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlfZTWM2OD12MEmuNlEhdk1?	M2r5UnNCVkeHUh?=
TGBC11TKB	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmjFTWM2OD12MUCuN\|Mhdk1?	MmfMV2FPT0WU
NCI-H727	NYHJfpJqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVrJR\|UxRTRzMj6xNUBvVQ>?	MV3TRW5ITVJ?
ALL-PO	NGXN[3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MljKTWM2OD12MUWuOlkhdk1?	M3:1d3NCVkeHUh?=
ABC-1	Mnq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYm2XXFNUUN3ME20NlAvPDVibl2=	NGraOnZUSU6JRWK=
NCI-H69	MmTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmLVTWM2OD12Mk[uO\|Yhdk1?	M3TLXnNCVkeHUh?=
GP5d	MnfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3rI[2lEPTB;NEO0MlQyKG6P	MXvTRW5ITVJ?
UMC-11	M1LiV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWfJR\|UxRTR3OD6zOkBvVQ>?	MVTTRW5ITVJ?
RMG-I	NXn4RnJDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUi0U4hwUUN3ME20OlcvPTZibl2=	NVvLSpc2W0GQR1XS
YAPC	MmPCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MU\JR\|UxRTR7MD62JI5O	Mn:5V2FPT0WU
LS-1034	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Moq0TWM2OD12OUGuNFYhdk1?	MlvtV2FPT0WU
RCM-1	M3rVbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4jOeWlEPTB;NEm2MlY5KG6P	MkPLV2FPT0WU
HCC1954	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4fYXmlEPTB;NUGyMlUhdk1?	NEDEOY1USU6JRWK=
SK-MEL-24	M1XGe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWXJR\|UxRTVzNj61NUBvVQ>?	NILo[Y9USU6JRWK=
NB12	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH21NGhKSzVyPUWyPE41OiCwTR?=	MUjTRW5ITVJ?
SW756	M1G2XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXj5R\|RHUUN3ME21OVQvQTZibl2=	Mle5V2FPT0WU
HCC1187	M17INWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mln1TWM2OD13N{WuPFMhdk1?	M4PKUHNCVkeHUh?=
NCI-H2342	NGjzXZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MofTTWM2OD13OUCuN\|khdk1?	MoXNV2FPT0WU
NCI-H2291	NYS3eXpMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1HEfGlEPTB;NUm4MlMyKG6P	NITpendUSU6JRWK=
OVCAR-3	Ml:wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnnOTWM2OD13OUiuPVYhdk1?	MX\TRW5ITVJ?
MHH-NB-11	M{D6Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mof3TWM2OD14MkmuNFEhdk1?	MY\TRW5ITVJ?
SAS	NUfuZXU6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWi3e4dwUUN3ME22OVIvPjdibl2=	NFq3SJZUSU6JRWK=
COLO-824	NEfTc3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV;JR\|UxRTZ6OT6zO{BvVQ>?	NVjGVXFZW0GQR1XS
HCC1395	M1HCbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVjJR\|UxRTZ7OD61JI5O	MoX5V2FPT0WU
COLO-668	M2fG[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFLCfFlKSzVyPUewOk4yKG6P	NULMfGZ5W0GQR1XS
NCI-H226	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHXOfIhKSzVyPUewO{45KG6P	Mlz4V2FPT0WU
NB17	MnPpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXjVeGpMUUN3ME23NlEvPzVibl2=	NW\lXWRDW0GQR1XS
SW1463	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXvJR\|UxRTd\|OT6xPUBvVQ>?	MVXTRW5ITVJ?
TGW	NU\I[XZlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYnFTJBnUUN3ME23OlAvOTVibl2=	MWnTRW5ITVJ?
NCI-H526	MkW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn[wTWM2OD16MkOuOVMhdk1?	MWDTRW5ITVJ?
COR-L88	NFi5O4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXjLZmQyUUN3ME24OFgvOTJibl2=	MV7TRW5ITVJ?
NCI-H441	MoPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXjqdmdVUUN3ME24PVUvOjJibl2=	M1nTVnNCVkeHUh?=
NCI-H630	M3\2RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{TRTGlEPTB;OUGyMlk3KG6P	NG\kOWdUSU6JRWK=
Mo-T	NXrJOYZXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYLJR\|UxRTl2Nz64PEBvVQ>?	MXPTRW5ITVJ?
JAR	MkHoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV\mPIpGUUN3ME25OVYvOjRibl2=	MXTTRW5ITVJ?
NCI-H1838	NVXicHN4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYnJR\|UxRTFwMEKzPFgh\|ryP	NHyxfppUSU6JRWK=
DoTc2-4510	M3v6ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmDUTWM2OD1zLkC3N\|c3KM7:TR?=	MV\TRW5ITVJ?
MKN28	MnLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3\5eWlEPTB;MT6wPVAzPCEQvF2=	M{jINnNCVkeHUh?=
HuP-T3	NFzrfWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWPJR\|UxRTFwMUG5NFUh\|ryP	MoP2V2FPT0WU
TE-9	NIrTfmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmXWTWM2OD1zLkGyPVc{KM7:TR?=	NV3MWFE4W0GQR1XS
NY	Mkf4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3LVNGlEPTB;MT6xOlc6OiEQvF2=	M4rO[nNCVkeHUh?=
HT55	M1PBfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVS3SJJQUUN3ME2xMlMyOzR2IN88US=>	NIDsSVZUSU6JRWK=
SW837	M2PVXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIXTSm1KSzVyPUGuN\|I6PzhizszN	NWntXFZ6W0GQR1XS
NCI-H2029	NWe4SG9wT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1TiWGlEPTB;MT60NVc6OSEQvF2=	NFjZdYxUSU6JRWK=
IST-SL1	Ml\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYDO[5lTUUN3ME2xMlQ1OjRizszN	Ml[0V2FPT0WU
COLO-741	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWntRZF{UUN3ME2xMlQ6PzdzIN88US=>	NHKzNVBUSU6JRWK=
LU-65	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUHJR\|UxRTFwNkKyOFkh\|ryP	NV7jPJdPW0GQR1XS
NCI-H1304	NV;FdlVLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXXwN5ZFUUN3ME2xMlY2PDl6IN88US=>	Mn7vV2FPT0WU
KARPAS-299	M4e2S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWPFWZoyUUN3ME2xMlc6PDd7IN88US=>	M2HOSnNCVkeHUh?=
NCI-H358	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NV62cHZJUUN3ME2xMlk2PTB\|IN88US=>	NFvuc4VUSU6JRWK=
OAW-28	MonrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUPJdIRuUUN3ME2yMlA3QTF7IN88US=>	NEHvNXZUSU6JRWK=
C8166	NF3DO2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkXxTWM2OD1{Lk[zN\|kzKM7:TR?=	NXjsUW1kW0GQR1XS
COLO-678	MlewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlGxTWM2OD1{LkizO\|Y5KM7:TR?=	M3XKeXNCVkeHUh?=
SK-N-DZ	NVz3dYdxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWfkdYNqUUN3ME2yMlg3OzhzIN88US=>	MXrTRW5ITVJ?
NCI-H82	MofjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mnm0TWM2OD1{LkmwN\|Y6KM7:TR?=	M1jWTHNCVkeHUh?=
JVM-2	MlWxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV\JR\|UxRTNwMEOxPFgh\|ryP	M2HWfHNCVkeHUh?=
SW1116	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUG1SVN[UUN3ME2zMlA2PDFzIN88US=>	NYXMeHAyW0GQR1XS
MDA-MB-453	NEnLRYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NU\2UYE6UUN3ME2zMlExPDN7IN88US=>	NWrlcnZ7W0GQR1XS
Calu-6	NFPWdpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3fybWlEPTB;Mz6xPVk4KM7:TR?=	M1;DOnNCVkeHUh?=
SHP-77	NXvNbnZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2j5bmlEPTB;Mz61Nlgh\|ryP	MUHTRW5ITVJ?
Capan-2	M3f6NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NE\kUHpKSzVyPUSuN\|I2QDFizszN	NYPJ[VJXW0GQR1XS
SW948	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYLJR\|UxRTRwN{S3O\|kh\|ryP	Mk\sV2FPT0WU
HDLM-2	Moi1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M17PXGlEPTB;NT6wO\|czPSEQvF2=	M2XXZXNCVkeHUh?=
LAN-6	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnzuTWM2OD14LkKxOFk2KM7:TR?=	NVL2NYdjW0GQR1XS
LU-135	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUPJR\|UxRTZwNEOwO\|ch\|ryP	NFflXZBUSU6JRWK=

研究领域

产品类型